Project
Illumina Body Map 2: averaged replicates
Navigation
Downloads
Results for BARHL1
Z-value: 3.07
Motif logo
Transcription factors associated with BARHL1
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
BARHL1
|
ENSG00000125492.5 | BarH like homeobox 1 |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| BARHL1 | hg19_v2_chr9_+_135458021_135458046 | -0.37 | 3.6e-02 | Click! |
Activity profile of BARHL1 motif
Sorted Z-values of BARHL1 motif
| Promoter | Log-likelihood | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr18_+_29171689 | 4.97 |
ENST00000237014.3
|
TTR
|
transthyretin |
| chr8_+_1993152 | 4.18 |
ENST00000262113.4
|
MYOM2
|
myomesin 2 |
| chr3_+_63428982 | 3.84 |
ENST00000479198.1
ENST00000460711.1 ENST00000465156.1 |
SYNPR
|
synaptoporin |
| chr14_+_32798462 | 3.77 |
ENST00000280979.4
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr13_-_114107839 | 3.76 |
ENST00000375418.3
|
ADPRHL1
|
ADP-ribosylhydrolase like 1 |
| chr5_+_140593509 | 3.65 |
ENST00000341948.4
|
PCDHB13
|
protocadherin beta 13 |
| chr13_+_30002741 | 3.61 |
ENST00000380808.2
|
MTUS2
|
microtubule associated tumor suppressor candidate 2 |
| chr11_+_27076764 | 3.46 |
ENST00000525090.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr14_+_32798547 | 3.46 |
ENST00000557354.1
ENST00000557102.1 ENST00000557272.1 |
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr8_+_1993173 | 3.44 |
ENST00000523438.1
|
MYOM2
|
myomesin 2 |
| chr4_-_186732892 | 3.44 |
ENST00000451958.1
ENST00000439914.1 ENST00000428330.1 ENST00000429056.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr9_-_112179990 | 3.38 |
ENST00000394827.3
|
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3 |
| chr8_+_79503458 | 3.34 |
ENST00000518467.1
|
PKIA
|
protein kinase (cAMP-dependent, catalytic) inhibitor alpha |
| chrX_+_46937745 | 3.28 |
ENST00000397180.1
ENST00000457380.1 ENST00000352078.4 |
RGN
|
regucalcin |
| chr4_-_186734275 | 3.20 |
ENST00000456060.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr11_+_27062272 | 3.19 |
ENST00000529202.1
ENST00000533566.1 |
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr4_-_186732048 | 3.15 |
ENST00000448662.2
ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr13_+_30002846 | 3.10 |
ENST00000542829.1
|
MTUS2
|
microtubule associated tumor suppressor candidate 2 |
| chrX_-_15333775 | 3.08 |
ENST00000480796.1
|
ASB11
|
ankyrin repeat and SOCS box containing 11 |
| chr4_-_186578674 | 3.08 |
ENST00000438278.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr6_+_53976211 | 2.98 |
ENST00000503951.1
|
MLIP
|
muscular LMNA-interacting protein |
| chr1_+_237205476 | 2.94 |
ENST00000366574.2
|
RYR2
|
ryanodine receptor 2 (cardiac) |
| chr6_+_53976235 | 2.92 |
ENST00000502396.1
ENST00000358276.5 |
MLIP
|
muscular LMNA-interacting protein |
| chr3_-_46608010 | 2.92 |
ENST00000395905.3
|
LRRC2
|
leucine rich repeat containing 2 |
| chr14_+_32964258 | 2.91 |
ENST00000556638.1
|
AKAP6
|
A kinase (PRKA) anchor protein 6 |
| chr18_+_68002675 | 2.90 |
ENST00000584919.1
|
RP11-41O4.1
|
Uncharacterized protein |
| chr10_+_69865866 | 2.88 |
ENST00000354393.2
|
MYPN
|
myopalladin |
| chr12_-_22063787 | 2.85 |
ENST00000544039.1
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
| chr20_-_62129163 | 2.85 |
ENST00000298049.7
|
EEF1A2
|
eukaryotic translation elongation factor 1 alpha 2 |
| chr18_-_48351743 | 2.84 |
ENST00000588444.1
ENST00000256425.2 ENST00000428869.2 |
MRO
|
maestro |
| chr10_+_18629628 | 2.78 |
ENST00000377329.4
|
CACNB2
|
calcium channel, voltage-dependent, beta 2 subunit |
| chr4_+_69962185 | 2.74 |
ENST00000305231.7
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr6_+_53883708 | 2.71 |
ENST00000514921.1
ENST00000274897.5 ENST00000370877.2 |
MLIP
|
muscular LMNA-interacting protein |
| chr1_+_197237352 | 2.68 |
ENST00000538660.1
ENST00000367400.3 ENST00000367399.2 |
CRB1
|
crumbs homolog 1 (Drosophila) |
| chr10_-_115423792 | 2.64 |
ENST00000369360.3
ENST00000360478.3 ENST00000359988.3 ENST00000369358.4 |
NRAP
|
nebulin-related anchoring protein |
| chr12_-_11091862 | 2.63 |
ENST00000537503.1
|
TAS2R14
|
taste receptor, type 2, member 14 |
| chr8_-_82359662 | 2.60 |
ENST00000519260.1
ENST00000256103.2 |
PMP2
|
peripheral myelin protein 2 |
| chr12_-_71551652 | 2.57 |
ENST00000546561.1
|
TSPAN8
|
tetraspanin 8 |
| chr12_-_71551868 | 2.57 |
ENST00000247829.3
|
TSPAN8
|
tetraspanin 8 |
| chr3_+_35722487 | 2.54 |
ENST00000441454.1
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr9_-_93405352 | 2.52 |
ENST00000375765.3
|
DIRAS2
|
DIRAS family, GTP-binding RAS-like 2 |
| chr9_-_104249400 | 2.51 |
ENST00000374848.3
|
TMEM246
|
transmembrane protein 246 |
| chr7_-_81635106 | 2.51 |
ENST00000443883.1
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
| chr3_+_42190714 | 2.50 |
ENST00000449246.1
|
TRAK1
|
trafficking protein, kinesin binding 1 |
| chr4_+_169575875 | 2.50 |
ENST00000503457.1
|
PALLD
|
palladin, cytoskeletal associated protein |
| chr11_+_27062502 | 2.47 |
ENST00000263182.3
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr18_+_32455201 | 2.46 |
ENST00000590831.2
|
DTNA
|
dystrobrevin, alpha |
| chr19_+_18726786 | 2.46 |
ENST00000594709.1
|
TMEM59L
|
transmembrane protein 59-like |
| chr12_-_11287243 | 2.39 |
ENST00000539585.1
|
TAS2R30
|
taste receptor, type 2, member 30 |
| chr10_+_7745303 | 2.39 |
ENST00000429820.1
ENST00000379587.4 |
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chr2_+_101591314 | 2.38 |
ENST00000450763.1
|
NPAS2
|
neuronal PAS domain protein 2 |
| chrX_-_49056635 | 2.37 |
ENST00000472598.1
ENST00000538567.1 ENST00000479808.1 ENST00000263233.4 |
SYP
|
synaptophysin |
| chr2_-_44550441 | 2.36 |
ENST00000420756.1
ENST00000444696.1 |
PREPL
|
prolyl endopeptidase-like |
| chr10_-_93392811 | 2.34 |
ENST00000238994.5
|
PPP1R3C
|
protein phosphatase 1, regulatory subunit 3C |
| chr2_-_179672142 | 2.34 |
ENST00000342992.6
ENST00000360870.5 ENST00000460472.2 ENST00000589042.1 ENST00000591111.1 ENST00000342175.6 ENST00000359218.5 |
TTN
|
titin |
| chr6_-_136788001 | 2.31 |
ENST00000544465.1
|
MAP7
|
microtubule-associated protein 7 |
| chrM_+_10464 | 2.31 |
ENST00000361335.1
|
MT-ND4L
|
mitochondrially encoded NADH dehydrogenase 4L |
| chr4_-_65275162 | 2.29 |
ENST00000381210.3
ENST00000507440.1 |
TECRL
|
trans-2,3-enoyl-CoA reductase-like |
| chr14_-_94421605 | 2.29 |
ENST00000556062.1
|
ASB2
|
ankyrin repeat and SOCS box containing 2 |
| chr3_-_196242233 | 2.29 |
ENST00000397537.2
|
SMCO1
|
single-pass membrane protein with coiled-coil domains 1 |
| chr3_+_63428752 | 2.26 |
ENST00000295894.5
|
SYNPR
|
synaptoporin |
| chr6_+_53964336 | 2.26 |
ENST00000447836.2
ENST00000511678.1 |
MLIP
|
muscular LMNA-interacting protein |
| chr4_-_186570679 | 2.26 |
ENST00000451974.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr8_+_91803695 | 2.26 |
ENST00000417640.2
|
NECAB1
|
N-terminal EF-hand calcium binding protein 1 |
| chr3_-_149293990 | 2.23 |
ENST00000472417.1
|
WWTR1
|
WW domain containing transcription regulator 1 |
| chr4_-_182186182 | 2.23 |
ENST00000512547.1
|
RP11-665C14.2
|
RP11-665C14.2 |
| chr2_+_133874577 | 2.23 |
ENST00000596384.1
|
AC011755.1
|
HCG2006742; Protein LOC100996685 |
| chr10_-_50970322 | 2.21 |
ENST00000374103.4
|
OGDHL
|
oxoglutarate dehydrogenase-like |
| chr20_+_5892037 | 2.21 |
ENST00000378961.4
|
CHGB
|
chromogranin B (secretogranin 1) |
| chrX_-_15511438 | 2.21 |
ENST00000380420.5
|
PIR
|
pirin (iron-binding nuclear protein) |
| chr1_-_85930246 | 2.20 |
ENST00000426972.3
|
DDAH1
|
dimethylarginine dimethylaminohydrolase 1 |
| chr14_+_100204027 | 2.12 |
ENST00000554479.1
ENST00000555145.1 |
EML1
|
echinoderm microtubule associated protein like 1 |
| chr7_-_82792215 | 2.09 |
ENST00000333891.9
ENST00000423517.2 |
PCLO
|
piccolo presynaptic cytomatrix protein |
| chr20_+_5892147 | 2.08 |
ENST00000455042.1
|
CHGB
|
chromogranin B (secretogranin 1) |
| chr6_-_135271219 | 2.08 |
ENST00000367847.2
ENST00000367845.2 |
ALDH8A1
|
aldehyde dehydrogenase 8 family, member A1 |
| chr5_+_78985673 | 2.08 |
ENST00000446378.2
|
CMYA5
|
cardiomyopathy associated 5 |
| chr2_+_11696464 | 2.08 |
ENST00000234142.5
|
GREB1
|
growth regulation by estrogen in breast cancer 1 |
| chr12_+_126107042 | 2.02 |
ENST00000535886.1
|
TMEM132B
|
transmembrane protein 132B |
| chr8_-_112039643 | 2.01 |
ENST00000524283.1
|
RP11-946L20.2
|
RP11-946L20.2 |
| chr5_-_149644944 | 2.01 |
ENST00000515758.1
|
CAMK2A
|
calcium/calmodulin-dependent protein kinase II alpha |
| chr18_+_32398326 | 2.00 |
ENST00000269192.7
ENST00000591182.1 ENST00000597674.1 ENST00000556414.3 |
DTNA
|
dystrobrevin, alpha |
| chr6_+_30856507 | 1.99 |
ENST00000513240.1
ENST00000424544.2 |
DDR1
|
discoidin domain receptor tyrosine kinase 1 |
| chr20_+_32782375 | 1.99 |
ENST00000568305.1
|
ASIP
|
agouti signaling protein |
| chr12_-_120189900 | 1.98 |
ENST00000546026.1
|
CIT
|
citron (rho-interacting, serine/threonine kinase 21) |
| chr8_+_99076750 | 1.98 |
ENST00000545282.1
|
C8orf47
|
chromosome 8 open reading frame 47 |
| chr4_-_141348763 | 1.98 |
ENST00000509477.1
|
CLGN
|
calmegin |
| chr18_-_48346415 | 1.98 |
ENST00000431965.2
ENST00000436348.2 |
MRO
|
maestro |
| chr6_+_53883790 | 1.98 |
ENST00000509997.1
|
MLIP
|
muscular LMNA-interacting protein |
| chr7_-_135412925 | 1.97 |
ENST00000354042.4
|
SLC13A4
|
solute carrier family 13 (sodium/sulfate symporter), member 4 |
| chr1_+_47533160 | 1.95 |
ENST00000334194.3
|
CYP4Z1
|
cytochrome P450, family 4, subfamily Z, polypeptide 1 |
| chr2_+_166150541 | 1.94 |
ENST00000283256.6
|
SCN2A
|
sodium channel, voltage-gated, type II, alpha subunit |
| chr10_+_24755416 | 1.93 |
ENST00000396446.1
ENST00000396445.1 ENST00000376451.2 |
KIAA1217
|
KIAA1217 |
| chr2_-_68547061 | 1.92 |
ENST00000263655.3
|
CNRIP1
|
cannabinoid receptor interacting protein 1 |
| chr21_+_40824003 | 1.92 |
ENST00000452550.1
|
SH3BGR
|
SH3 domain binding glutamic acid-rich protein |
| chr1_-_163172625 | 1.92 |
ENST00000527988.1
ENST00000531476.1 ENST00000530507.1 |
RGS5
|
regulator of G-protein signaling 5 |
| chr1_+_100111580 | 1.92 |
ENST00000605497.1
|
PALMD
|
palmdelphin |
| chr13_-_114103443 | 1.91 |
ENST00000356501.4
ENST00000413169.2 |
ADPRHL1
|
ADP-ribosylhydrolase like 1 |
| chrM_+_10758 | 1.91 |
ENST00000361381.2
|
MT-ND4
|
mitochondrially encoded NADH dehydrogenase 4 |
| chr8_-_97247759 | 1.90 |
ENST00000518406.1
ENST00000523920.1 ENST00000287022.5 |
UQCRB
|
ubiquinol-cytochrome c reductase binding protein |
| chr11_-_118047376 | 1.90 |
ENST00000278947.5
|
SCN2B
|
sodium channel, voltage-gated, type II, beta subunit |
| chr1_-_60392452 | 1.90 |
ENST00000371204.3
|
CYP2J2
|
cytochrome P450, family 2, subfamily J, polypeptide 2 |
| chr4_+_78829479 | 1.90 |
ENST00000504901.1
|
MRPL1
|
mitochondrial ribosomal protein L1 |
| chr17_-_55911970 | 1.89 |
ENST00000581805.1
ENST00000580960.1 |
RP11-60A24.3
|
RP11-60A24.3 |
| chr3_+_26735991 | 1.89 |
ENST00000456208.2
|
LRRC3B
|
leucine rich repeat containing 3B |
| chr10_-_50970382 | 1.89 |
ENST00000419399.1
ENST00000432695.1 |
OGDHL
|
oxoglutarate dehydrogenase-like |
| chr1_-_68915610 | 1.89 |
ENST00000262340.5
|
RPE65
|
retinal pigment epithelium-specific protein 65kDa |
| chr5_-_41261540 | 1.88 |
ENST00000263413.3
|
C6
|
complement component 6 |
| chr4_+_71600063 | 1.88 |
ENST00000513597.1
|
RUFY3
|
RUN and FYVE domain containing 3 |
| chr2_+_233527443 | 1.87 |
ENST00000410095.1
|
EFHD1
|
EF-hand domain family, member D1 |
| chr4_-_70361615 | 1.87 |
ENST00000305107.6
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4 |
| chr10_-_127505167 | 1.87 |
ENST00000368786.1
|
UROS
|
uroporphyrinogen III synthase |
| chr18_+_18943554 | 1.87 |
ENST00000580732.2
|
GREB1L
|
growth regulation by estrogen in breast cancer-like |
| chr5_+_43602750 | 1.86 |
ENST00000505678.2
ENST00000512422.1 ENST00000264663.5 |
NNT
|
nicotinamide nucleotide transhydrogenase |
| chr4_+_159131346 | 1.84 |
ENST00000508243.1
ENST00000296529.6 |
TMEM144
|
transmembrane protein 144 |
| chr5_-_11588907 | 1.84 |
ENST00000513598.1
ENST00000503622.1 |
CTNND2
|
catenin (cadherin-associated protein), delta 2 |
| chr9_+_108463234 | 1.84 |
ENST00000374688.1
|
TMEM38B
|
transmembrane protein 38B |
| chr10_-_69597915 | 1.83 |
ENST00000225171.2
|
DNAJC12
|
DnaJ (Hsp40) homolog, subfamily C, member 12 |
| chr10_-_97321112 | 1.83 |
ENST00000607232.1
ENST00000371227.4 ENST00000371249.2 ENST00000371247.2 ENST00000371246.2 ENST00000393949.1 ENST00000353505.5 ENST00000347291.4 |
SORBS1
|
sorbin and SH3 domain containing 1 |
| chr11_+_27062860 | 1.83 |
ENST00000528583.1
|
BBOX1
|
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
| chr15_-_45670717 | 1.82 |
ENST00000558163.1
ENST00000558336.1 |
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
| chr10_-_61899124 | 1.81 |
ENST00000373815.1
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
| chr4_-_186877502 | 1.81 |
ENST00000431902.1
ENST00000284776.7 ENST00000415274.1 |
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr18_+_32398400 | 1.81 |
ENST00000599844.1
|
DTNA
|
dystrobrevin, alpha |
| chr12_+_26348246 | 1.79 |
ENST00000422622.2
|
SSPN
|
sarcospan |
| chr3_+_186383741 | 1.79 |
ENST00000232003.4
|
HRG
|
histidine-rich glycoprotein |
| chr2_+_183943464 | 1.78 |
ENST00000354221.4
|
DUSP19
|
dual specificity phosphatase 19 |
| chr4_-_22444733 | 1.78 |
ENST00000508133.1
|
GPR125
|
G protein-coupled receptor 125 |
| chr5_-_147211226 | 1.78 |
ENST00000296695.5
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1 |
| chr12_-_91573249 | 1.77 |
ENST00000550099.1
ENST00000546391.1 ENST00000551354.1 |
DCN
|
decorin |
| chr4_+_69962212 | 1.77 |
ENST00000508661.1
|
UGT2B7
|
UDP glucuronosyltransferase 2 family, polypeptide B7 |
| chr1_-_144866711 | 1.76 |
ENST00000530130.1
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr10_+_7745232 | 1.75 |
ENST00000358415.4
|
ITIH2
|
inter-alpha-trypsin inhibitor heavy chain 2 |
| chr3_-_187009646 | 1.74 |
ENST00000296280.6
ENST00000392470.2 ENST00000169293.6 ENST00000439271.1 ENST00000392472.2 ENST00000392475.2 |
MASP1
|
mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) |
| chr3_+_35722844 | 1.74 |
ENST00000436702.1
ENST00000438071.1 |
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr3_+_35722424 | 1.73 |
ENST00000396481.2
|
ARPP21
|
cAMP-regulated phosphoprotein, 21kDa |
| chr4_+_76995855 | 1.73 |
ENST00000355810.4
ENST00000349321.3 |
ART3
|
ADP-ribosyltransferase 3 |
| chr12_+_111374375 | 1.73 |
ENST00000553177.1
ENST00000548368.1 ENST00000331096.2 ENST00000547607.1 |
RP1-46F2.2
|
RP1-46F2.2 |
| chr17_-_57604227 | 1.72 |
ENST00000584262.1
|
RP11-567L7.6
|
RP11-567L7.6 |
| chr12_-_10978957 | 1.72 |
ENST00000240619.2
|
TAS2R10
|
taste receptor, type 2, member 10 |
| chr6_-_84419101 | 1.72 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
| chr12_-_86650077 | 1.72 |
ENST00000552808.2
ENST00000547225.1 |
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
| chr12_+_69202975 | 1.72 |
ENST00000544561.1
ENST00000393410.1 ENST00000299252.4 ENST00000360430.2 ENST00000517852.1 ENST00000545204.1 ENST00000393413.3 ENST00000350057.5 ENST00000348801.2 ENST00000478070.1 |
MDM2
|
MDM2 oncogene, E3 ubiquitin protein ligase |
| chr4_-_65275100 | 1.72 |
ENST00000509536.1
|
TECRL
|
trans-2,3-enoyl-CoA reductase-like |
| chr8_+_19536083 | 1.72 |
ENST00000519803.1
|
RP11-1105O14.1
|
RP11-1105O14.1 |
| chr10_-_99161033 | 1.72 |
ENST00000315563.6
ENST00000370992.4 ENST00000414986.1 |
RRP12
|
ribosomal RNA processing 12 homolog (S. cerevisiae) |
| chrX_-_139866723 | 1.71 |
ENST00000370532.2
|
CDR1
|
cerebellar degeneration-related protein 1, 34kDa |
| chrX_-_15333736 | 1.71 |
ENST00000380470.3
|
ASB11
|
ankyrin repeat and SOCS box containing 11 |
| chr8_-_18744528 | 1.70 |
ENST00000523619.1
|
PSD3
|
pleckstrin and Sec7 domain containing 3 |
| chr5_-_125930929 | 1.70 |
ENST00000553117.1
ENST00000447989.2 ENST00000409134.3 |
ALDH7A1
|
aldehyde dehydrogenase 7 family, member A1 |
| chr15_+_71228826 | 1.70 |
ENST00000558456.1
ENST00000560158.2 ENST00000558808.1 ENST00000559806.1 ENST00000559069.1 |
LRRC49
|
leucine rich repeat containing 49 |
| chr7_-_14880892 | 1.70 |
ENST00000406247.3
ENST00000399322.3 ENST00000258767.5 |
DGKB
|
diacylglycerol kinase, beta 90kDa |
| chr8_+_99076509 | 1.68 |
ENST00000318528.3
|
C8orf47
|
chromosome 8 open reading frame 47 |
| chr5_+_140579162 | 1.68 |
ENST00000536699.1
ENST00000354757.3 |
PCDHB11
|
protocadherin beta 11 |
| chr5_-_102898465 | 1.67 |
ENST00000507423.1
ENST00000230792.2 |
NUDT12
|
nudix (nucleoside diphosphate linked moiety X)-type motif 12 |
| chr3_+_156807663 | 1.66 |
ENST00000467995.1
ENST00000474477.1 ENST00000471719.1 |
LINC00881
|
long intergenic non-protein coding RNA 881 |
| chr2_-_100939195 | 1.65 |
ENST00000393437.3
|
LONRF2
|
LON peptidase N-terminal domain and ring finger 2 |
| chr19_-_36643329 | 1.65 |
ENST00000589154.1
|
COX7A1
|
cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) |
| chr20_+_56964169 | 1.64 |
ENST00000475243.1
|
VAPB
|
VAMP (vesicle-associated membrane protein)-associated protein B and C |
| chr8_-_42396185 | 1.63 |
ENST00000518717.1
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
| chr9_-_19786926 | 1.63 |
ENST00000341998.2
ENST00000286344.3 |
SLC24A2
|
solute carrier family 24 (sodium/potassium/calcium exchanger), member 2 |
| chr12_-_22094336 | 1.63 |
ENST00000326684.4
|
ABCC9
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
| chr19_-_44388116 | 1.63 |
ENST00000587539.1
|
ZNF404
|
zinc finger protein 404 |
| chr6_+_29624758 | 1.61 |
ENST00000376917.3
ENST00000376902.3 ENST00000533330.2 ENST00000376888.2 |
MOG
|
myelin oligodendrocyte glycoprotein |
| chr14_+_20811766 | 1.61 |
ENST00000250416.5
ENST00000527915.1 |
PARP2
|
poly (ADP-ribose) polymerase 2 |
| chr8_+_120885949 | 1.61 |
ENST00000523492.1
ENST00000286234.5 |
DEPTOR
|
DEP domain containing MTOR-interacting protein |
| chr7_-_121784285 | 1.61 |
ENST00000417368.2
|
AASS
|
aminoadipate-semialdehyde synthase |
| chr12_-_86650154 | 1.61 |
ENST00000552435.2
|
MGAT4C
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
| chr4_+_159131630 | 1.61 |
ENST00000504569.1
ENST00000509278.1 ENST00000514558.1 ENST00000503200.1 |
TMEM144
|
transmembrane protein 144 |
| chr1_-_145076186 | 1.60 |
ENST00000369348.3
|
PDE4DIP
|
phosphodiesterase 4D interacting protein |
| chr15_-_27018884 | 1.60 |
ENST00000299267.4
|
GABRB3
|
gamma-aminobutyric acid (GABA) A receptor, beta 3 |
| chr13_+_111855399 | 1.60 |
ENST00000426768.2
|
ARHGEF7
|
Rho guanine nucleotide exchange factor (GEF) 7 |
| chr20_+_36974759 | 1.60 |
ENST00000217407.2
|
LBP
|
lipopolysaccharide binding protein |
| chr6_-_28303901 | 1.60 |
ENST00000439158.1
ENST00000446474.1 ENST00000414431.1 ENST00000344279.6 ENST00000453745.1 |
ZSCAN31
|
zinc finger and SCAN domain containing 31 |
| chr10_+_53806501 | 1.59 |
ENST00000373975.2
|
PRKG1
|
protein kinase, cGMP-dependent, type I |
| chr16_+_8814563 | 1.58 |
ENST00000425191.2
ENST00000569156.1 |
ABAT
|
4-aminobutyrate aminotransferase |
| chr6_+_153552455 | 1.58 |
ENST00000392385.2
|
AL590867.1
|
Uncharacterized protein; cDNA FLJ59044, highly similar to LINE-1 reverse transcriptase homolog |
| chr7_-_129691201 | 1.58 |
ENST00000480193.1
ENST00000360708.5 ENST00000311873.5 ENST00000481503.1 ENST00000358303.4 |
ZC3HC1
|
zinc finger, C3HC-type containing 1 |
| chr8_+_120079478 | 1.57 |
ENST00000332843.2
|
COLEC10
|
collectin sub-family member 10 (C-type lectin) |
| chr4_+_159131596 | 1.57 |
ENST00000512481.1
|
TMEM144
|
transmembrane protein 144 |
| chr4_-_69536346 | 1.56 |
ENST00000338206.5
|
UGT2B15
|
UDP glucuronosyltransferase 2 family, polypeptide B15 |
| chr4_-_70361579 | 1.55 |
ENST00000512583.1
|
UGT2B4
|
UDP glucuronosyltransferase 2 family, polypeptide B4 |
| chr19_+_45409011 | 1.54 |
ENST00000252486.4
ENST00000446996.1 ENST00000434152.1 |
APOE
|
apolipoprotein E |
| chr18_+_55862622 | 1.54 |
ENST00000456173.2
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
| chr15_-_45670924 | 1.53 |
ENST00000396659.3
|
GATM
|
glycine amidinotransferase (L-arginine:glycine amidinotransferase) |
| chr2_+_234826016 | 1.53 |
ENST00000324695.4
ENST00000433712.2 |
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8 |
| chr4_-_186732241 | 1.53 |
ENST00000421639.1
|
SORBS2
|
sorbin and SH3 domain containing 2 |
| chr22_+_21133469 | 1.53 |
ENST00000406799.1
|
SERPIND1
|
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
| chr3_+_111717511 | 1.52 |
ENST00000478951.1
ENST00000393917.2 |
TAGLN3
|
transgelin 3 |
| chr5_+_140514782 | 1.51 |
ENST00000231134.5
|
PCDHB5
|
protocadherin beta 5 |
| chr4_+_166300084 | 1.51 |
ENST00000402744.4
|
CPE
|
carboxypeptidase E |
| chr6_+_143759575 | 1.51 |
ENST00000595616.1
|
AL031320.1
|
AL031320.1 |
| chr18_-_40857493 | 1.51 |
ENST00000255224.3
|
SYT4
|
synaptotagmin IV |
| chr11_+_65266507 | 1.51 |
ENST00000544868.1
|
MALAT1
|
metastasis associated lung adenocarcinoma transcript 1 (non-protein coding) |
| chr3_+_145782358 | 1.51 |
ENST00000422482.1
|
AC107021.1
|
HCG1786590; PRO2533; Uncharacterized protein |
| chr5_+_36606700 | 1.50 |
ENST00000416645.2
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3 |
| chr13_+_76413852 | 1.50 |
ENST00000533809.2
|
LMO7
|
LIM domain 7 |
| chrX_+_10126488 | 1.50 |
ENST00000380829.1
ENST00000421085.2 ENST00000454850.1 |
CLCN4
|
chloride channel, voltage-sensitive 4 |
| chr10_-_61900762 | 1.50 |
ENST00000355288.2
|
ANK3
|
ankyrin 3, node of Ranvier (ankyrin G) |
| chr12_-_54982420 | 1.50 |
ENST00000257905.8
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
| chr15_+_58702742 | 1.49 |
ENST00000356113.6
ENST00000414170.3 |
LIPC
|
lipase, hepatic |
Network of associatons between targets according to the STRING database.
First level regulatory network of BARHL1
Gene Ontology Analysis
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 10.1 | GO:1902261 | positive regulation of delayed rectifier potassium channel activity(GO:1902261) |
| 1.2 | 6.2 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
| 1.2 | 4.6 | GO:0006601 | creatine biosynthetic process(GO:0006601) |
| 1.1 | 3.4 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
| 1.1 | 3.4 | GO:0006711 | estrogen catabolic process(GO:0006711) |
| 1.1 | 3.3 | GO:0048174 | negative regulation of short-term neuronal synaptic plasticity(GO:0048174) |
| 1.0 | 9.5 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
| 0.9 | 11.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
| 0.8 | 4.1 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.8 | 4.0 | GO:0003095 | pressure natriuresis(GO:0003095) |
| 0.8 | 4.7 | GO:1900827 | maintenance of protein location in membrane(GO:0072658) maintenance of protein location in plasma membrane(GO:0072660) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.8 | 2.3 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
| 0.8 | 0.8 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
| 0.7 | 2.2 | GO:1904404 | cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.7 | 6.1 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
| 0.7 | 5.4 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
| 0.7 | 2.6 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
| 0.6 | 30.6 | GO:0003298 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.6 | 1.9 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
| 0.6 | 9.3 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
| 0.6 | 1.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.6 | 2.9 | GO:0070352 | positive regulation of white fat cell proliferation(GO:0070352) |
| 0.6 | 1.8 | GO:0051758 | homologous chromosome movement towards spindle pole involved in homologous chromosome segregation(GO:0051758) |
| 0.6 | 1.7 | GO:1903718 | carbamoyl phosphate metabolic process(GO:0070408) carbamoyl phosphate biosynthetic process(GO:0070409) response to ammonia(GO:1903717) cellular response to ammonia(GO:1903718) |
| 0.6 | 0.6 | GO:0006154 | adenosine catabolic process(GO:0006154) inosine biosynthetic process(GO:0046103) |
| 0.6 | 4.0 | GO:0035995 | skeletal muscle myosin thick filament assembly(GO:0030241) detection of muscle stretch(GO:0035995) |
| 0.6 | 2.3 | GO:0051066 | dihydrobiopterin metabolic process(GO:0051066) |
| 0.6 | 1.7 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.5 | 0.5 | GO:0036367 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
| 0.5 | 0.5 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
| 0.5 | 1.5 | GO:2000646 | lipid transport involved in lipid storage(GO:0010877) positive regulation of receptor catabolic process(GO:2000646) |
| 0.5 | 1.5 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
| 0.5 | 1.5 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 | 2.9 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
| 0.5 | 2.4 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.5 | 2.8 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
| 0.5 | 1.4 | GO:0052331 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
| 0.5 | 2.3 | GO:0000957 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
| 0.5 | 1.4 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.5 | 1.4 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
| 0.5 | 0.9 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.5 | 1.8 | GO:0006740 | NADPH regeneration(GO:0006740) |
| 0.4 | 2.7 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
| 0.4 | 0.9 | GO:1901877 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
| 0.4 | 0.4 | GO:0090212 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
| 0.4 | 1.8 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
| 0.4 | 3.5 | GO:1902722 | positive regulation of prolactin secretion(GO:1902722) |
| 0.4 | 1.3 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
| 0.4 | 9.9 | GO:0052695 | cellular glucuronidation(GO:0052695) |
| 0.4 | 2.6 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
| 0.4 | 1.7 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
| 0.4 | 1.3 | GO:0042214 | terpene metabolic process(GO:0042214) |
| 0.4 | 3.3 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.4 | 1.6 | GO:0048789 | cytoskeletal matrix organization at active zone(GO:0048789) neurexin clustering involved in presynaptic membrane assembly(GO:0097115) retrograde trans-synaptic signaling by trans-synaptic protein complex(GO:0098942) |
| 0.4 | 1.2 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
| 0.4 | 2.0 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
| 0.4 | 4.3 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
| 0.4 | 3.1 | GO:0071918 | urea transmembrane transport(GO:0071918) |
| 0.4 | 2.7 | GO:0050955 | thermoception(GO:0050955) |
| 0.4 | 5.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.4 | 1.9 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
| 0.4 | 1.9 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
| 0.4 | 2.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
| 0.4 | 1.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.4 | 1.1 | GO:0006106 | fumarate metabolic process(GO:0006106) aspartate biosynthetic process(GO:0006532) aspartate catabolic process(GO:0006533) |
| 0.4 | 1.1 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
| 0.3 | 1.0 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.3 | 1.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
| 0.3 | 1.4 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.3 | 1.0 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.3 | 0.7 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.3 | 1.0 | GO:0043438 | acetoacetic acid metabolic process(GO:0043438) |
| 0.3 | 1.4 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.3 | 1.0 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.3 | 5.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.3 | 1.0 | GO:0061026 | cardiac muscle tissue regeneration(GO:0061026) |
| 0.3 | 1.9 | GO:0046684 | response to pyrethroid(GO:0046684) |
| 0.3 | 0.9 | GO:0046823 | negative regulation of nucleocytoplasmic transport(GO:0046823) |
| 0.3 | 1.9 | GO:0015853 | adenine transport(GO:0015853) |
| 0.3 | 1.2 | GO:0034343 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.3 | 1.2 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
| 0.3 | 0.6 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.3 | 1.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
| 0.3 | 2.1 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
| 0.3 | 4.8 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
| 0.3 | 0.9 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.3 | 2.1 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
| 0.3 | 1.2 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
| 0.3 | 1.4 | GO:0030070 | insulin processing(GO:0030070) |
| 0.3 | 4.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.3 | 1.4 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
| 0.3 | 4.1 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.3 | 12.1 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.3 | 3.8 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.3 | 1.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.3 | 0.8 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
| 0.3 | 1.9 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.3 | 1.6 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
| 0.3 | 11.2 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.3 | 2.6 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
| 0.3 | 2.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
| 0.3 | 1.3 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) operant conditioning(GO:0035106) |
| 0.3 | 1.0 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
| 0.3 | 0.3 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
| 0.3 | 1.0 | GO:0034255 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
| 0.3 | 1.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.2 | 0.7 | GO:0042660 | positive regulation of cell fate specification(GO:0042660) |
| 0.2 | 0.7 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.2 | 1.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
| 0.2 | 1.0 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.2 | 1.2 | GO:0048496 | maintenance of organ identity(GO:0048496) |
| 0.2 | 1.0 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
| 0.2 | 2.4 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.2 | 1.7 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
| 0.2 | 2.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
| 0.2 | 0.7 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 0.2 | 1.4 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
| 0.2 | 0.2 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) |
| 0.2 | 0.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.2 | 0.9 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
| 0.2 | 0.5 | GO:0045917 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.2 | 3.1 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
| 0.2 | 0.9 | GO:1903770 | regulation of telomere maintenance via recombination(GO:0032207) negative regulation of telomere maintenance via recombination(GO:0032208) negative regulation of single strand break repair(GO:1903517) negative regulation of beta-galactosidase activity(GO:1903770) telomere single strand break repair(GO:1903823) negative regulation of telomere single strand break repair(GO:1903824) |
| 0.2 | 2.1 | GO:0090063 | positive regulation of microtubule nucleation(GO:0090063) |
| 0.2 | 1.8 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.2 | 1.2 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.2 | 0.5 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
| 0.2 | 0.7 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
| 0.2 | 2.1 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
| 0.2 | 4.1 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.2 | 0.9 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
| 0.2 | 0.9 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.2 | 0.7 | GO:2001247 | positive regulation of phosphatidylcholine biosynthetic process(GO:2001247) |
| 0.2 | 1.1 | GO:0098907 | protein localization to T-tubule(GO:0036371) regulation of SA node cell action potential(GO:0098907) |
| 0.2 | 2.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
| 0.2 | 0.9 | GO:0018874 | benzoate metabolic process(GO:0018874) |
| 0.2 | 1.1 | GO:0000270 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
| 0.2 | 2.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.2 | 4.6 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.2 | 1.1 | GO:0010513 | positive regulation of phosphatidylinositol biosynthetic process(GO:0010513) |
| 0.2 | 0.9 | GO:1990169 | detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.2 | 0.4 | GO:0070434 | positive regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070426) positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070434) |
| 0.2 | 3.1 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.2 | 0.9 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
| 0.2 | 4.5 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.2 | 2.8 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.2 | 3.2 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.2 | 0.8 | GO:0034334 | adherens junction maintenance(GO:0034334) |
| 0.2 | 0.6 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
| 0.2 | 1.3 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
| 0.2 | 1.1 | GO:1902741 | type I interferon secretion(GO:0072641) interferon-alpha secretion(GO:0072642) regulation of interferon-alpha secretion(GO:1902739) positive regulation of interferon-alpha secretion(GO:1902741) |
| 0.2 | 0.6 | GO:0018963 | insecticide metabolic process(GO:0017143) dibenzo-p-dioxin metabolic process(GO:0018894) phthalate metabolic process(GO:0018963) |
| 0.2 | 0.8 | GO:0050976 | detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.2 | 1.0 | GO:0046092 | deoxycytidine metabolic process(GO:0046092) |
| 0.2 | 0.6 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.2 | 0.6 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
| 0.2 | 2.1 | GO:0042737 | drug catabolic process(GO:0042737) |
| 0.2 | 15.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.2 | 1.0 | GO:0009107 | lipoate metabolic process(GO:0009106) lipoate biosynthetic process(GO:0009107) |
| 0.2 | 1.0 | GO:1990535 | neuron projection maintenance(GO:1990535) |
| 0.2 | 2.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
| 0.2 | 0.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.2 | 2.8 | GO:0015705 | iodide transport(GO:0015705) |
| 0.2 | 0.6 | GO:1990764 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.2 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
| 0.2 | 0.8 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) uroporphyrinogen III metabolic process(GO:0046502) |
| 0.2 | 2.0 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.2 | 2.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
| 0.2 | 1.2 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.2 | 2.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.2 | 0.8 | GO:0072302 | negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 0.2 | 1.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.2 | 1.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
| 0.2 | 1.7 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.2 | 3.8 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.2 | 3.8 | GO:0051775 | response to redox state(GO:0051775) |
| 0.2 | 1.3 | GO:0051012 | microtubule sliding(GO:0051012) |
| 0.2 | 1.7 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.2 | 1.1 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
| 0.2 | 3.9 | GO:0044557 | relaxation of smooth muscle(GO:0044557) |
| 0.2 | 0.7 | GO:2000866 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
| 0.2 | 1.3 | GO:0048165 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
| 0.2 | 0.6 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
| 0.2 | 0.6 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.2 | 0.9 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
| 0.2 | 0.9 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
| 0.2 | 0.6 | GO:0043060 | meiotic metaphase I plate congression(GO:0043060) meiotic spindle midzone assembly(GO:0051257) meiotic metaphase plate congression(GO:0051311) |
| 0.2 | 0.2 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
| 0.2 | 3.6 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 | 3.8 | GO:0033141 | positive regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033141) |
| 0.2 | 0.5 | GO:0061713 | neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 0.2 | 1.3 | GO:2001023 | regulation of response to drug(GO:2001023) |
| 0.2 | 0.9 | GO:0006777 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.2 | 0.5 | GO:0006919 | activation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0006919) |
| 0.2 | 0.9 | GO:2000768 | glomerular parietal epithelial cell differentiation(GO:0072139) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.2 | 0.9 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
| 0.2 | 0.5 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
| 0.2 | 1.9 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.2 | 0.5 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
| 0.2 | 0.5 | GO:0051097 | negative regulation of helicase activity(GO:0051097) |
| 0.2 | 3.7 | GO:0016559 | peroxisome fission(GO:0016559) |
| 0.2 | 0.4 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
| 0.2 | 3.1 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
| 0.2 | 1.0 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
| 0.2 | 0.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.2 | 0.2 | GO:0009441 | glycolate metabolic process(GO:0009441) |
| 0.2 | 0.7 | GO:0097696 | JAK-STAT cascade(GO:0007259) STAT cascade(GO:0097696) |
| 0.2 | 2.2 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
| 0.2 | 0.3 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
| 0.2 | 0.7 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
| 0.2 | 1.0 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
| 0.2 | 0.7 | GO:0023021 | termination of signal transduction(GO:0023021) |
| 0.2 | 0.5 | GO:0045645 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 0.2 | 0.8 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 5.1 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.2 | 0.7 | GO:0016094 | polyprenol biosynthetic process(GO:0016094) |
| 0.2 | 0.5 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
| 0.2 | 0.7 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.2 | 1.1 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
| 0.2 | 1.0 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 | 0.7 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
| 0.2 | 1.3 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
| 0.2 | 1.1 | GO:0003172 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) |
| 0.2 | 1.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
| 0.2 | 3.3 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.2 | 0.9 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.2 | 1.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.2 | 0.3 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
| 0.2 | 1.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
| 0.2 | 0.9 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.2 | 1.4 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
| 0.2 | 1.7 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.2 | 4.5 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.2 | 0.2 | GO:0032213 | regulation of telomere maintenance via semi-conservative replication(GO:0032213) negative regulation of telomere maintenance via semi-conservative replication(GO:0032214) |
| 0.2 | 0.5 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
| 0.2 | 0.5 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 | 1.2 | GO:0007405 | neuroblast proliferation(GO:0007405) |
| 0.2 | 1.2 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.2 | 1.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.2 | 2.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 | 1.2 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
| 0.1 | 0.6 | GO:1901842 | negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 | 0.4 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
| 0.1 | 0.3 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 | 2.8 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 0.7 | GO:0051182 | coenzyme transport(GO:0051182) |
| 0.1 | 2.8 | GO:0045475 | locomotor rhythm(GO:0045475) |
| 0.1 | 2.0 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.6 | GO:0009597 | detection of virus(GO:0009597) |
| 0.1 | 0.6 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
| 0.1 | 0.3 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
| 0.1 | 0.3 | GO:1990641 | response to iron ion starvation(GO:1990641) negative regulation of CD8-positive, alpha-beta T cell activation(GO:2001186) |
| 0.1 | 0.4 | GO:1901142 | insulin metabolic process(GO:1901142) |
| 0.1 | 1.0 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.1 | 1.0 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.1 | 1.3 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
| 0.1 | 2.1 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
| 0.1 | 0.6 | GO:0048747 | muscle fiber development(GO:0048747) |
| 0.1 | 0.6 | GO:0048936 | peripheral nervous system neuron axonogenesis(GO:0048936) |
| 0.1 | 2.2 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
| 0.1 | 0.7 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
| 0.1 | 7.7 | GO:0007274 | neuromuscular synaptic transmission(GO:0007274) |
| 0.1 | 2.3 | GO:0015747 | urate transport(GO:0015747) |
| 0.1 | 0.7 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 1.1 | GO:0007197 | adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway(GO:0007197) |
| 0.1 | 2.7 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.1 | 0.4 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
| 0.1 | 0.5 | GO:0060723 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
| 0.1 | 0.4 | GO:0071922 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
| 0.1 | 0.7 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.1 | 0.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.1 | 3.6 | GO:0003334 | keratinocyte development(GO:0003334) |
| 0.1 | 1.1 | GO:1905150 | regulation of voltage-gated sodium channel activity(GO:1905150) |
| 0.1 | 0.7 | GO:2000638 | regulation of SREBP signaling pathway(GO:2000638) negative regulation of SREBP signaling pathway(GO:2000639) |
| 0.1 | 1.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.1 | 3.0 | GO:0071420 | cellular response to histamine(GO:0071420) |
| 0.1 | 0.5 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.1 | 0.5 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
| 0.1 | 2.2 | GO:0008627 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 | 0.8 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
| 0.1 | 1.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
| 0.1 | 0.6 | GO:0090370 | negative regulation of cholesterol efflux(GO:0090370) |
| 0.1 | 0.6 | GO:1900106 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.1 | 1.1 | GO:0097338 | response to clozapine(GO:0097338) |
| 0.1 | 0.1 | GO:0030193 | regulation of blood coagulation(GO:0030193) regulation of hemostasis(GO:1900046) |
| 0.1 | 0.4 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
| 0.1 | 1.6 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
| 0.1 | 2.0 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
| 0.1 | 0.3 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
| 0.1 | 0.6 | GO:0046533 | negative regulation of photoreceptor cell differentiation(GO:0046533) |
| 0.1 | 0.5 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.1 | 0.9 | GO:0034201 | response to oleic acid(GO:0034201) |
| 0.1 | 0.5 | GO:0044376 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.1 | 2.1 | GO:1904903 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
| 0.1 | 0.4 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
| 0.1 | 0.4 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
| 0.1 | 0.9 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
| 0.1 | 2.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.1 | 0.6 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.1 | 1.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
| 0.1 | 0.4 | GO:0097359 | UDP-glucosylation(GO:0097359) |
| 0.1 | 0.4 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
| 0.1 | 2.8 | GO:0071578 | zinc II ion transmembrane import(GO:0071578) |
| 0.1 | 1.0 | GO:0015811 | L-cystine transport(GO:0015811) |
| 0.1 | 1.6 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.1 | 0.7 | GO:0015887 | biotin transport(GO:0015878) pantothenate transmembrane transport(GO:0015887) |
| 0.1 | 1.2 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.1 | 1.9 | GO:1901017 | negative regulation of potassium ion transmembrane transporter activity(GO:1901017) |
| 0.1 | 2.1 | GO:0046606 | negative regulation of centrosome cycle(GO:0046606) |
| 0.1 | 2.0 | GO:1904322 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
| 0.1 | 0.7 | GO:0030047 | actin modification(GO:0030047) |
| 0.1 | 0.2 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) positive regulation of histone H3-K79 methylation(GO:2001162) |
| 0.1 | 2.0 | GO:0099515 | vesicle transport along actin filament(GO:0030050) actin filament-based transport(GO:0099515) |
| 0.1 | 4.2 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
| 0.1 | 14.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
| 0.1 | 2.2 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
| 0.1 | 3.5 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 1.5 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 | 0.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.1 | 0.7 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.1 | 0.7 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 | 0.5 | GO:0034476 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
| 0.1 | 0.8 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.1 | 2.3 | GO:0015865 | purine nucleotide transport(GO:0015865) |
| 0.1 | 0.4 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
| 0.1 | 0.6 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.1 | 0.3 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
| 0.1 | 1.5 | GO:0097475 | motor neuron migration(GO:0097475) |
| 0.1 | 3.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.1 | 0.3 | GO:1904428 | negative regulation of tubulin deacetylation(GO:1904428) |
| 0.1 | 0.4 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 | 2.9 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.1 | 0.4 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.1 | 1.0 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.1 | 0.4 | GO:1903242 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
| 0.1 | 6.9 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.1 | 2.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
| 0.1 | 0.9 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 | 1.4 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
| 0.1 | 0.9 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
| 0.1 | 0.7 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
| 0.1 | 0.6 | GO:0051792 | medium-chain fatty acid biosynthetic process(GO:0051792) |
| 0.1 | 0.4 | GO:0006408 | snRNA export from nucleus(GO:0006408) |
| 0.1 | 0.9 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.1 | 0.2 | GO:0051389 | inactivation of MAPKK activity(GO:0051389) |
| 0.1 | 1.7 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 | 1.2 | GO:0046415 | urate metabolic process(GO:0046415) |
| 0.1 | 0.2 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
| 0.1 | 0.5 | GO:0030807 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 0.1 | 0.4 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
| 0.1 | 1.0 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.1 | 0.3 | GO:1900110 | negative regulation of histone H3-K9 dimethylation(GO:1900110) |
| 0.1 | 0.3 | GO:0001942 | hair follicle development(GO:0001942) molting cycle process(GO:0022404) hair cycle process(GO:0022405) skin epidermis development(GO:0098773) |
| 0.1 | 1.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.1 | 1.5 | GO:0086016 | AV node cell action potential(GO:0086016) AV node cell to bundle of His cell signaling(GO:0086027) |
| 0.1 | 0.3 | GO:0098507 | polynucleotide 5' dephosphorylation(GO:0098507) |
| 0.1 | 0.3 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
| 0.1 | 0.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.1 | 2.4 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.1 | 0.4 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
| 0.1 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
| 0.1 | 0.2 | GO:0010002 | cardioblast differentiation(GO:0010002) |
| 0.1 | 0.3 | GO:0090427 | activation of meiosis(GO:0090427) |
| 0.1 | 1.0 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.1 | 0.4 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
| 0.1 | 0.5 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
| 0.1 | 2.7 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.1 | 0.7 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
| 0.1 | 1.9 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.1 | 0.6 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
| 0.1 | 0.5 | GO:0032099 | negative regulation of response to food(GO:0032096) negative regulation of appetite(GO:0032099) |
| 0.1 | 0.3 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
| 0.1 | 1.9 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
| 0.1 | 0.6 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.1 | 1.1 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
| 0.1 | 0.5 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
| 0.1 | 0.4 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.1 | 0.6 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.1 | 0.5 | GO:0014832 | urinary bladder smooth muscle contraction(GO:0014832) urinary tract smooth muscle contraction(GO:0014848) |
| 0.1 | 0.3 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
| 0.1 | 0.6 | GO:0051414 | response to cortisol(GO:0051414) |
| 0.1 | 4.0 | GO:0042407 | cristae formation(GO:0042407) |
| 0.1 | 0.3 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
| 0.1 | 1.2 | GO:0015074 | DNA integration(GO:0015074) |
| 0.1 | 0.8 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
| 0.1 | 0.5 | GO:0033490 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
| 0.1 | 0.5 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) |
| 0.1 | 0.6 | GO:0019695 | choline metabolic process(GO:0019695) |
| 0.1 | 0.2 | GO:0003166 | bundle of His development(GO:0003166) |
| 0.1 | 0.4 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
| 0.1 | 0.4 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
| 0.1 | 0.4 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 | 0.5 | GO:0090487 | toxin catabolic process(GO:0009407) secondary metabolite catabolic process(GO:0090487) |
| 0.1 | 1.6 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 | 1.7 | GO:0008595 | tripartite regional subdivision(GO:0007351) anterior/posterior axis specification, embryo(GO:0008595) |
| 0.1 | 0.7 | GO:0070475 | rRNA base methylation(GO:0070475) |
| 0.1 | 0.8 | GO:0030242 | pexophagy(GO:0030242) |
| 0.1 | 0.8 | GO:0072393 | microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
| 0.1 | 0.5 | GO:0072752 | cellular response to rapamycin(GO:0072752) |
| 0.1 | 1.5 | GO:0060088 | auditory receptor cell stereocilium organization(GO:0060088) |
| 0.1 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
| 0.1 | 1.2 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
| 0.1 | 0.8 | GO:1901731 | calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.1 | 0.5 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 0.3 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
| 0.1 | 0.9 | GO:0060281 | regulation of oocyte development(GO:0060281) regulation of oocyte maturation(GO:1900193) |
| 0.1 | 0.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.1 | 0.6 | GO:1902572 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
| 0.1 | 1.2 | GO:0015886 | heme transport(GO:0015886) |
| 0.1 | 1.0 | GO:0050974 | detection of mechanical stimulus involved in sensory perception(GO:0050974) |
| 0.1 | 0.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.1 | 1.5 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 0.1 | 0.3 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
| 0.1 | 0.9 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
| 0.1 | 0.4 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
| 0.1 | 0.6 | GO:0034091 | regulation of maintenance of sister chromatid cohesion(GO:0034091) regulation of maintenance of mitotic sister chromatid cohesion(GO:0034182) |
| 0.1 | 0.2 | GO:0097198 | histone H3-K36 trimethylation(GO:0097198) |
| 0.1 | 0.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 0.4 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
| 0.1 | 1.1 | GO:0001501 | skeletal system development(GO:0001501) |
| 0.1 | 0.7 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
| 0.1 | 1.8 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 | 0.8 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.1 | 1.1 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 | 1.1 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
| 0.1 | 2.7 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
| 0.1 | 2.9 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 0.6 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.1 | 0.2 | GO:0035522 | monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 | 1.2 | GO:0045792 | negative regulation of cell size(GO:0045792) |
| 0.1 | 0.3 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
| 0.1 | 0.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
| 0.1 | 0.6 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.1 | 1.7 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.1 | 0.2 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
| 0.1 | 2.4 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
| 0.1 | 1.4 | GO:0005513 | detection of calcium ion(GO:0005513) |
| 0.1 | 1.7 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.6 | GO:2000676 | positive regulation of type B pancreatic cell apoptotic process(GO:2000676) |
| 0.1 | 0.7 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
| 0.1 | 0.5 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
| 0.1 | 2.5 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.1 | 0.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.1 | 0.4 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.1 | 0.7 | GO:0036109 | alpha-linolenic acid metabolic process(GO:0036109) |
| 0.1 | 0.5 | GO:0031179 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
| 0.1 | 2.3 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
| 0.1 | 2.0 | GO:2000651 | positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
| 0.1 | 0.7 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
| 0.1 | 1.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
| 0.1 | 0.5 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
| 0.1 | 0.6 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 1.1 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
| 0.1 | 1.3 | GO:0051043 | regulation of membrane protein ectodomain proteolysis(GO:0051043) |
| 0.1 | 1.3 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.1 | 1.7 | GO:0051531 | NFAT protein import into nucleus(GO:0051531) |
| 0.1 | 0.9 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
| 0.1 | 0.3 | GO:0071872 | cellular response to epinephrine stimulus(GO:0071872) |
| 0.1 | 2.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.1 | 0.8 | GO:0048793 | pronephros development(GO:0048793) |
| 0.1 | 0.1 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
| 0.1 | 0.4 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
| 0.1 | 1.7 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
| 0.1 | 1.2 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) apoptotic nuclear changes(GO:0030262) |
| 0.1 | 0.4 | GO:0052027 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.1 | 0.4 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.1 | 1.4 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
| 0.1 | 0.4 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
| 0.1 | 0.4 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
| 0.1 | 0.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
| 0.1 | 0.2 | GO:0001983 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 0.1 | 0.6 | GO:0048840 | otolith development(GO:0048840) |
| 0.1 | 0.4 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.1 | 0.3 | GO:0010453 | regulation of cell fate commitment(GO:0010453) |
| 0.1 | 0.9 | GO:0008090 | retrograde axonal transport(GO:0008090) |
| 0.1 | 0.4 | GO:1990592 | protein polyufmylation(GO:1990564) protein K69-linked ufmylation(GO:1990592) |
| 0.1 | 2.3 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 0.2 | GO:1901340 | negative regulation of store-operated calcium channel activity(GO:1901340) |
| 0.1 | 0.9 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
| 0.1 | 1.6 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
| 0.1 | 0.2 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) endoplasmic reticulum membrane organization(GO:0090158) |
| 0.1 | 2.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.1 | 1.3 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.1 | 0.5 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
| 0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.1 | 0.3 | GO:0071442 | regulation of histone H3-K14 acetylation(GO:0071440) positive regulation of histone H3-K14 acetylation(GO:0071442) |
| 0.1 | 0.3 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
| 0.1 | 1.9 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 0.3 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
| 0.1 | 2.7 | GO:0030488 | tRNA methylation(GO:0030488) |
| 0.1 | 0.3 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 | 0.3 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.1 | 0.1 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
| 0.1 | 0.6 | GO:0071971 | extracellular exosome assembly(GO:0071971) regulation of extracellular exosome assembly(GO:1903551) |
| 0.1 | 0.2 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
| 0.1 | 0.3 | GO:0090410 | malonate catabolic process(GO:0090410) |
| 0.1 | 0.9 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.1 | 0.1 | GO:1900365 | positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.1 | 1.2 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
| 0.1 | 3.4 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.1 | 0.5 | GO:0071389 | cellular response to mineralocorticoid stimulus(GO:0071389) |
| 0.1 | 0.5 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
| 0.1 | 4.3 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
| 0.1 | 4.2 | GO:0021762 | substantia nigra development(GO:0021762) |
| 0.1 | 1.9 | GO:0035418 | protein localization to synapse(GO:0035418) |
| 0.1 | 0.4 | GO:0009438 | methylglyoxal metabolic process(GO:0009438) |
| 0.1 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.4 | GO:0014904 | myotube cell development(GO:0014904) |
| 0.1 | 1.0 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
| 0.1 | 1.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.2 | GO:0035568 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
| 0.1 | 0.5 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
| 0.1 | 0.7 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 | 0.7 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.1 | 0.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
| 0.1 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.1 | 0.6 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
| 0.1 | 0.7 | GO:0003413 | chondrocyte differentiation involved in endochondral bone morphogenesis(GO:0003413) |
| 0.1 | 0.8 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
| 0.1 | 0.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 | 0.6 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.1 | 1.1 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
| 0.1 | 0.8 | GO:0007628 | adult walking behavior(GO:0007628) |
| 0.1 | 0.2 | GO:0070346 | positive regulation of fat cell proliferation(GO:0070346) |
| 0.1 | 0.9 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.1 | 0.2 | GO:0006423 | cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 | 0.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.1 | 0.3 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.1 | 1.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
| 0.1 | 0.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
| 0.1 | 0.3 | GO:0051030 | snRNA transport(GO:0051030) snRNA import into nucleus(GO:0061015) |
| 0.1 | 0.6 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.1 | 0.2 | GO:0051836 | translocation of peptides or proteins into host(GO:0042000) translocation of peptides or proteins into host cell cytoplasm(GO:0044053) translocation of molecules into host(GO:0044417) translocation of peptides or proteins into other organism involved in symbiotic interaction(GO:0051808) translocation of molecules into other organism involved in symbiotic interaction(GO:0051836) |
| 0.1 | 0.4 | GO:0071630 | nucleus-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071630) |
| 0.1 | 0.5 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 0.4 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 0.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 0.3 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
| 0.1 | 0.3 | GO:0009249 | protein lipoylation(GO:0009249) |
| 0.1 | 0.1 | GO:1903487 | regulation of lactation(GO:1903487) |
| 0.1 | 5.8 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 0.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.1 | 1.0 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.8 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
| 0.1 | 0.4 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 | 0.3 | GO:0071874 | cellular response to norepinephrine stimulus(GO:0071874) |
| 0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.1 | 1.0 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.1 | 0.5 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
| 0.1 | 0.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.1 | 0.2 | GO:0042268 | regulation of cytolysis(GO:0042268) |
| 0.1 | 0.4 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.1 | 0.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
| 0.1 | 0.6 | GO:0007638 | mechanosensory behavior(GO:0007638) |
| 0.1 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
| 0.1 | 0.1 | GO:0016246 | RNA interference(GO:0016246) |
| 0.1 | 0.2 | GO:0055091 | negative regulation of lipoprotein lipase activity(GO:0051005) phospholipid homeostasis(GO:0055091) |
| 0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.1 | 0.2 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
| 0.1 | 0.8 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
| 0.1 | 0.3 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 0.6 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.1 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 1.3 | GO:1901016 | regulation of potassium ion transmembrane transporter activity(GO:1901016) |
| 0.1 | 0.6 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
| 0.1 | 0.2 | GO:0045188 | optic nerve structural organization(GO:0021633) circadian sleep/wake cycle, non-REM sleep(GO:0042748) regulation of circadian sleep/wake cycle, non-REM sleep(GO:0045188) |
| 0.1 | 0.6 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 | 0.3 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
| 0.1 | 1.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.1 | 0.4 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.0 | 0.1 | GO:1903336 | intralumenal vesicle formation(GO:0070676) negative regulation of vacuolar transport(GO:1903336) |
| 0.0 | 0.1 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
| 0.0 | 0.3 | GO:0098703 | calcium ion import across plasma membrane(GO:0098703) calcium ion import into cell(GO:1990035) |
| 0.0 | 0.8 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.0 | 0.4 | GO:0060313 | negative regulation of neutrophil degranulation(GO:0043314) negative regulation of blood vessel remodeling(GO:0060313) |
| 0.0 | 1.1 | GO:0042755 | eating behavior(GO:0042755) |
| 0.0 | 0.6 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
| 0.0 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
| 0.0 | 0.5 | GO:0043297 | apical junction assembly(GO:0043297) bicellular tight junction assembly(GO:0070830) |
| 0.0 | 0.4 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.0 | 1.8 | GO:0051602 | response to electrical stimulus(GO:0051602) |
| 0.0 | 0.9 | GO:0010506 | regulation of autophagy(GO:0010506) |
| 0.0 | 5.7 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
| 0.0 | 0.4 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.0 | 0.9 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
| 0.0 | 0.0 | GO:0072422 | signal transduction involved in DNA integrity checkpoint(GO:0072401) signal transduction involved in DNA damage checkpoint(GO:0072422) |
| 0.0 | 0.7 | GO:0007160 | cell-matrix adhesion(GO:0007160) |
| 0.0 | 2.6 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.0 | 0.2 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.0 | 0.5 | GO:0018105 | peptidyl-serine phosphorylation(GO:0018105) |
| 0.0 | 0.8 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
| 0.0 | 0.1 | GO:1904117 | response to vasopressin(GO:1904116) cellular response to vasopressin(GO:1904117) |
| 0.0 | 0.8 | GO:0002674 | negative regulation of acute inflammatory response(GO:0002674) |
| 0.0 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.0 | 0.7 | GO:0007184 | SMAD protein import into nucleus(GO:0007184) |
| 0.0 | 1.0 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
| 0.0 | 0.3 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.0 | 0.5 | GO:0045176 | apical protein localization(GO:0045176) |
| 0.0 | 0.5 | GO:0046852 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
| 0.0 | 2.2 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
| 0.0 | 0.6 | GO:0006853 | carnitine shuttle(GO:0006853) |
| 0.0 | 0.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
| 0.0 | 0.2 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
| 0.0 | 0.7 | GO:0035640 | exploration behavior(GO:0035640) |
| 0.0 | 0.2 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
| 0.0 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.0 | 0.3 | GO:0015692 | lead ion transport(GO:0015692) |
| 0.0 | 1.7 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 1.8 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.0 | 1.0 | GO:1901663 | ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
| 0.0 | 0.4 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
| 0.0 | 0.3 | GO:0061726 | mitophagy(GO:0000422) mitochondrion disassembly(GO:0061726) |
| 0.0 | 0.3 | GO:0046034 | ATP metabolic process(GO:0046034) |
| 0.0 | 1.2 | GO:0042417 | dopamine metabolic process(GO:0042417) |
| 0.0 | 1.2 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.0 | 0.5 | GO:0060259 | regulation of feeding behavior(GO:0060259) |
| 0.0 | 0.6 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.0 | 0.5 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.0 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 0.0 | 1.2 | GO:0014047 | glutamate secretion(GO:0014047) |
| 0.0 | 0.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
| 0.0 | 0.2 | GO:0070982 | L-asparagine biosynthetic process(GO:0070981) L-asparagine metabolic process(GO:0070982) |
| 0.0 | 1.5 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
| 0.0 | 0.1 | GO:0000472 | endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000472) rRNA 5'-end processing(GO:0000967) ncRNA 5'-end processing(GO:0034471) |
| 0.0 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
| 0.0 | 0.6 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.0 | 0.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 0.7 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.0 | 0.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.0 | 0.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
| 0.0 | 0.2 | GO:0007059 | chromosome segregation(GO:0007059) |
| 0.0 | 0.7 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.0 | 0.5 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
| 0.0 | 1.4 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.0 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.0 | 0.2 | GO:0045898 | regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045898) |
| 0.0 | 0.6 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.0 | 0.2 | GO:0035234 | ectopic germ cell programmed cell death(GO:0035234) |
| 0.0 | 0.2 | GO:0045837 | negative regulation of membrane potential(GO:0045837) |
| 0.0 | 1.1 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.0 | 0.3 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.0 | 0.5 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
| 0.0 | 0.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 | 0.6 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
| 0.0 | 0.5 | GO:0051642 | centrosome localization(GO:0051642) |
| 0.0 | 0.4 | GO:0043647 | inositol phosphate metabolic process(GO:0043647) |
| 0.0 | 0.3 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.0 | 0.1 | GO:0071264 | regulation of eIF2 alpha phosphorylation by amino acid starvation(GO:0060733) regulation of translational initiation in response to starvation(GO:0071262) positive regulation of translational initiation in response to starvation(GO:0071264) |
| 0.0 | 0.4 | GO:0010765 | positive regulation of sodium ion transport(GO:0010765) |
| 0.0 | 1.2 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.0 | 0.5 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
| 0.0 | 0.3 | GO:0006930 | substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.3 | GO:0022613 | ribonucleoprotein complex biogenesis(GO:0022613) ribosome biogenesis(GO:0042254) |
| 0.0 | 1.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.4 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
| 0.0 | 0.1 | GO:0060972 | left/right pattern formation(GO:0060972) |
| 0.0 | 0.7 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
| 0.0 | 0.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.0 | 0.5 | GO:0035994 | response to muscle stretch(GO:0035994) |
| 0.0 | 0.3 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.0 | 0.8 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.0 | 0.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.0 | 0.2 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
| 0.0 | 0.9 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 | 0.3 | GO:0010265 | SCF complex assembly(GO:0010265) |
| 0.0 | 0.1 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
| 0.0 | 0.1 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
| 0.0 | 0.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.0 | 0.4 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
| 0.0 | 0.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.0 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
| 0.0 | 0.7 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.0 | 0.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.0 | 0.3 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.0 | 0.4 | GO:0016556 | mRNA modification(GO:0016556) |
| 0.0 | 0.1 | GO:0000132 | establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 | 0.5 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 | 0.3 | GO:0003322 | pancreatic A cell development(GO:0003322) |
| 0.0 | 0.1 | GO:1903202 | negative regulation of oxidative stress-induced cell death(GO:1903202) |
| 0.0 | 0.2 | GO:0009213 | pyrimidine nucleoside triphosphate catabolic process(GO:0009149) pyrimidine deoxyribonucleoside triphosphate catabolic process(GO:0009213) |
| 0.0 | 0.6 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.0 | 0.6 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
| 0.0 | 0.5 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 | 2.7 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.0 | 0.9 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
| 0.0 | 1.2 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.0 | 0.2 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.0 | 0.3 | GO:0044062 | regulation of excretion(GO:0044062) |
| 0.0 | 0.2 | GO:0051931 | regulation of sensory perception of pain(GO:0051930) regulation of sensory perception(GO:0051931) |
| 0.0 | 0.9 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.0 | 2.0 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.0 | 0.5 | GO:0035269 | protein mannosylation(GO:0035268) protein O-linked mannosylation(GO:0035269) |
| 0.0 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 | 0.3 | GO:0042733 | embryonic digit morphogenesis(GO:0042733) |
| 0.0 | 0.5 | GO:0060004 | reflex(GO:0060004) |
| 0.0 | 0.3 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
| 0.0 | 0.3 | GO:0017144 | drug metabolic process(GO:0017144) |
| 0.0 | 0.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.0 | 0.1 | GO:0019049 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
| 0.0 | 2.0 | GO:0006409 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
| 0.0 | 0.6 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.0 | 0.2 | GO:0097017 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) renal protein absorption(GO:0097017) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.0 | 0.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
| 0.0 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
| 0.0 | 0.5 | GO:0097320 | membrane tubulation(GO:0097320) |
| 0.0 | 1.2 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
| 0.0 | 0.3 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
| 0.0 | 0.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
| 0.0 | 0.1 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.0 | 20.5 | GO:0043687 | post-translational protein modification(GO:0043687) |
| 0.0 | 2.5 | GO:0005977 | glycogen metabolic process(GO:0005977) |
| 0.0 | 0.2 | GO:0032410 | negative regulation of transporter activity(GO:0032410) |
| 0.0 | 0.6 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 | 0.2 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
| 0.0 | 0.2 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
| 0.0 | 0.2 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
| 0.0 | 0.5 | GO:0090160 | Golgi to lysosome transport(GO:0090160) |
| 0.0 | 2.5 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 | 0.4 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
| 0.0 | 0.1 | GO:0036292 | DNA rewinding(GO:0036292) |
| 0.0 | 0.6 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.0 | 0.2 | GO:0048010 | vascular endothelial growth factor receptor signaling pathway(GO:0048010) |
| 0.0 | 0.1 | GO:0046035 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
| 0.0 | 0.7 | GO:0006914 | autophagy(GO:0006914) |
| 0.0 | 1.8 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.4 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 | 0.2 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.0 | 0.2 | GO:0007512 | adult heart development(GO:0007512) |
| 0.0 | 1.1 | GO:0050771 | negative regulation of axonogenesis(GO:0050771) |
| 0.0 | 0.4 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.0 | 0.5 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
| 0.0 | 0.3 | GO:0006013 | mannose metabolic process(GO:0006013) |
| 0.0 | 0.4 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
| 0.0 | 0.4 | GO:0090051 | negative regulation of cell migration involved in sprouting angiogenesis(GO:0090051) negative regulation of sprouting angiogenesis(GO:1903671) |
| 0.0 | 0.2 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.0 | 4.9 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.7 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
| 0.0 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.0 | 0.4 | GO:0021554 | optic nerve development(GO:0021554) |
| 0.0 | 0.3 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.0 | 0.6 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
| 0.0 | 0.2 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
| 0.0 | 0.1 | GO:0071030 | nuclear mRNA surveillance of spliceosomal pre-mRNA splicing(GO:0071030) nuclear retention of unspliced pre-mRNA at the site of transcription(GO:0071048) |
| 0.0 | 0.3 | GO:0045793 | positive regulation of cell size(GO:0045793) |
| 0.0 | 0.1 | GO:0035750 | protein localization to myelin sheath abaxonal region(GO:0035750) |
| 0.0 | 0.4 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.0 | 0.3 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.0 | 1.8 | GO:0006611 | protein export from nucleus(GO:0006611) |
| 0.0 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.0 | 0.2 | GO:2000391 | positive regulation of neutrophil extravasation(GO:2000391) positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.0 | 0.2 | GO:0060180 | negative regulation of female receptivity(GO:0007621) regulation of female receptivity(GO:0045924) female mating behavior(GO:0060180) |
| 0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 | 0.1 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
| 0.0 | 0.4 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.0 | 1.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
| 0.0 | 0.3 | GO:0021924 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
| 0.0 | 1.8 | GO:0006303 | double-strand break repair via nonhomologous end joining(GO:0006303) |
| 0.0 | 0.1 | GO:0032990 | cell part morphogenesis(GO:0032990) |
| 0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.0 | 0.1 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.0 | 0.1 | GO:0046889 | positive regulation of lipid biosynthetic process(GO:0046889) |
| 0.0 | 0.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.0 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
| 0.0 | 0.4 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
| 0.0 | 0.4 | GO:0098792 | xenophagy(GO:0098792) |
| 0.0 | 0.5 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
| 0.0 | 0.2 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 | 1.4 | GO:0033275 | muscle filament sliding(GO:0030049) actin-myosin filament sliding(GO:0033275) |
| 0.0 | 0.1 | GO:0006045 | N-acetylglucosamine biosynthetic process(GO:0006045) glucosamine-containing compound biosynthetic process(GO:1901073) |
| 0.0 | 0.9 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) negative regulation of biomineral tissue development(GO:0070168) |
| 0.0 | 0.2 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
| 0.0 | 0.6 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
| 0.0 | 1.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.0 | 0.2 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
| 0.0 | 0.1 | GO:0036269 | swimming behavior(GO:0036269) |
| 0.0 | 0.1 | GO:0001578 | microtubule bundle formation(GO:0001578) |
| 0.0 | 0.1 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 | 0.1 | GO:1904106 | protein localization to microvillus(GO:1904106) |
| 0.0 | 0.0 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
| 0.0 | 0.1 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
| 0.0 | 0.3 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
| 0.0 | 0.9 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
| 0.0 | 0.1 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
| 0.0 | 0.8 | GO:0010761 | fibroblast migration(GO:0010761) |
| 0.0 | 0.5 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
| 0.0 | 0.2 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.0 | 0.5 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
| 0.0 | 0.3 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
| 0.0 | 0.6 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
| 0.0 | 0.4 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.0 | 0.6 | GO:0051764 | actin crosslink formation(GO:0051764) |
| 0.0 | 0.6 | GO:0034394 | protein localization to cell surface(GO:0034394) |
| 0.0 | 0.2 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.0 | 1.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.1 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
| 0.0 | 0.2 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 | 1.6 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.0 | 0.1 | GO:0032268 | regulation of cellular protein metabolic process(GO:0032268) |
| 0.0 | 0.4 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
| 0.0 | 0.1 | GO:0033198 | response to ATP(GO:0033198) |
| 0.0 | 0.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
| 0.0 | 0.3 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.0 | 0.3 | GO:0007528 | neuromuscular junction development(GO:0007528) |
| 0.0 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.0 | 0.1 | GO:0072235 | ascending thin limb development(GO:0072021) thick ascending limb development(GO:0072023) distal convoluted tubule development(GO:0072025) metanephric ascending thin limb development(GO:0072218) metanephric distal convoluted tubule development(GO:0072221) metanephric thick ascending limb development(GO:0072233) metanephric distal tubule development(GO:0072235) |
| 0.0 | 0.5 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 | 0.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.0 | 0.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.5 | GO:0010977 | negative regulation of neuron projection development(GO:0010977) |
| 0.0 | 4.7 | GO:0007050 | cell cycle arrest(GO:0007050) |
| 0.0 | 1.6 | GO:1990830 | response to leukemia inhibitory factor(GO:1990823) cellular response to leukemia inhibitory factor(GO:1990830) |
| 0.0 | 0.1 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 | 0.2 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
| 0.0 | 0.6 | GO:0016601 | Rac protein signal transduction(GO:0016601) |
| 0.0 | 0.9 | GO:0000045 | autophagosome assembly(GO:0000045) |
| 0.0 | 0.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
| 0.0 | 0.2 | GO:0010842 | retina layer formation(GO:0010842) |
| 0.0 | 0.3 | GO:0048511 | rhythmic process(GO:0048511) |
| 0.0 | 0.2 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
| 0.0 | 0.2 | GO:0051601 | exocyst localization(GO:0051601) |
| 0.0 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.0 | 0.9 | GO:0001570 | vasculogenesis(GO:0001570) |
| 0.0 | 0.0 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.0 | 0.8 | GO:0032259 | methylation(GO:0032259) |
| 0.0 | 4.0 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.0 | 0.3 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
| 0.0 | 0.4 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.0 | 0.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.0 | 0.2 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.1 | GO:0097484 | dendrite extension(GO:0097484) |
| 0.0 | 0.1 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.0 | 0.2 | GO:0071988 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
| 0.0 | 0.4 | GO:0048286 | lung alveolus development(GO:0048286) |
| 0.0 | 0.4 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
| 0.0 | 0.4 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
| 0.0 | 0.2 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
| 0.0 | 0.2 | GO:0045333 | cellular respiration(GO:0045333) |
| 0.0 | 1.2 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 | 0.5 | GO:0007631 | feeding behavior(GO:0007631) |
| 0.0 | 0.5 | GO:0006836 | neurotransmitter transport(GO:0006836) |
| 0.0 | 0.2 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 | 0.6 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
| 0.0 | 0.1 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
| 0.0 | 0.3 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
| 0.0 | 0.4 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.0 | 0.1 | GO:0000717 | nucleotide-excision repair, DNA duplex unwinding(GO:0000717) |
| 0.0 | 0.2 | GO:0097050 | type B pancreatic cell apoptotic process(GO:0097050) regulation of type B pancreatic cell apoptotic process(GO:2000674) |
| 0.0 | 0.1 | GO:0034453 | microtubule anchoring(GO:0034453) |
| 0.0 | 0.1 | GO:0001934 | positive regulation of protein phosphorylation(GO:0001934) |
| 0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
| 0.0 | 0.0 | GO:0050728 | negative regulation of inflammatory response(GO:0050728) |
| 0.0 | 0.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
| 0.0 | 0.2 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
| 0.0 | 0.1 | GO:0006335 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.0 | 0.0 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
| 0.0 | 0.5 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
| 0.0 | 0.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
| 0.0 | 0.0 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
| 0.0 | 0.4 | GO:0060338 | regulation of type I interferon-mediated signaling pathway(GO:0060338) |
| 0.0 | 0.2 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
| 0.0 | 0.4 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
| 0.0 | 0.2 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
| 0.0 | 0.1 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
| 0.0 | 0.1 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.0 | 1.1 | GO:0006672 | ceramide metabolic process(GO:0006672) |
| 0.0 | 0.2 | GO:0034063 | stress granule assembly(GO:0034063) |
| 0.0 | 0.9 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
| 0.0 | 0.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
| 0.0 | 0.2 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
| 0.0 | 0.1 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
| 0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
| 0.0 | 0.6 | GO:0008286 | insulin receptor signaling pathway(GO:0008286) |
| 0.0 | 1.1 | GO:0060047 | heart contraction(GO:0060047) |
| 0.0 | 0.2 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.0 | 0.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
| 0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
| 0.0 | 0.2 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
| 0.0 | 0.3 | GO:0048806 | genitalia development(GO:0048806) |
| 0.0 | 0.1 | GO:1901032 | cell death in response to hydrogen peroxide(GO:0036474) negative regulation of response to reactive oxygen species(GO:1901032) regulation of hydrogen peroxide-induced cell death(GO:1903205) negative regulation of hydrogen peroxide-induced cell death(GO:1903206) |
| 0.0 | 0.3 | GO:0045844 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 13.8 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
| 0.7 | 6.0 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
| 0.7 | 3.3 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.6 | 4.2 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.6 | 1.7 | GO:0097489 | multivesicular body, internal vesicle lumen(GO:0097489) |
| 0.5 | 7.8 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.5 | 1.5 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
| 0.4 | 2.6 | GO:0005927 | muscle tendon junction(GO:0005927) |
| 0.4 | 5.2 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
| 0.4 | 2.4 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
| 0.4 | 1.8 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.4 | 1.8 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
| 0.4 | 0.4 | GO:0098803 | respiratory chain complex(GO:0098803) |
| 0.3 | 11.1 | GO:0032982 | myosin filament(GO:0032982) |
| 0.3 | 6.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.3 | 10.5 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.3 | 4.7 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.3 | 4.4 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.3 | 0.9 | GO:0097451 | glial limiting end-foot(GO:0097451) |
| 0.3 | 0.9 | GO:1903095 | microprocessor complex(GO:0070877) ribonuclease III complex(GO:1903095) |
| 0.3 | 0.9 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.3 | 6.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.3 | 9.1 | GO:0043194 | axon initial segment(GO:0043194) |
| 0.3 | 2.8 | GO:0005579 | membrane attack complex(GO:0005579) |
| 0.3 | 1.4 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.3 | 1.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.3 | 0.5 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
| 0.3 | 2.6 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
| 0.3 | 2.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.3 | 0.8 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
| 0.3 | 1.6 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.3 | 2.5 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.2 | 2.5 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
| 0.2 | 0.7 | GO:0005595 | collagen type XII trimer(GO:0005595) |
| 0.2 | 0.7 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.2 | 59.5 | GO:0030018 | Z disc(GO:0030018) |
| 0.2 | 0.2 | GO:0048475 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
| 0.2 | 1.1 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
| 0.2 | 2.2 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.2 | 1.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.2 | 4.5 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 15.2 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
| 0.2 | 0.6 | GO:0036117 | hyaluranon cable(GO:0036117) |
| 0.2 | 1.5 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
| 0.2 | 3.1 | GO:0098562 | cytoplasmic side of plasma membrane(GO:0009898) cytoplasmic side of membrane(GO:0098562) |
| 0.2 | 2.1 | GO:0044305 | calyx of Held(GO:0044305) |
| 0.2 | 0.8 | GO:0005712 | chiasma(GO:0005712) |
| 0.2 | 0.6 | GO:0034515 | proteasome storage granule(GO:0034515) |
| 0.2 | 1.2 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
| 0.2 | 0.8 | GO:0034271 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
| 0.2 | 1.0 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
| 0.2 | 1.7 | GO:1990578 | perinuclear endoplasmic reticulum membrane(GO:1990578) |
| 0.2 | 8.3 | GO:0005746 | mitochondrial respiratory chain(GO:0005746) |
| 0.2 | 0.6 | GO:0036457 | keratohyalin granule(GO:0036457) |
| 0.2 | 0.7 | GO:0031592 | centrosomal corona(GO:0031592) |
| 0.2 | 5.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
| 0.2 | 1.3 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.2 | 4.8 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
| 0.2 | 1.3 | GO:1990635 | proximal dendrite(GO:1990635) |
| 0.2 | 5.2 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.2 | 0.8 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
| 0.2 | 0.9 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.2 | 2.7 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.2 | 2.6 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
| 0.2 | 2.0 | GO:0017059 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
| 0.1 | 1.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
| 0.1 | 0.4 | GO:1902636 | kinociliary basal body(GO:1902636) |
| 0.1 | 6.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 0.6 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
| 0.1 | 0.4 | GO:1990716 | axonemal central apparatus(GO:1990716) |
| 0.1 | 1.5 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.1 | 2.6 | GO:0035371 | microtubule plus-end(GO:0035371) |
| 0.1 | 1.8 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
| 0.1 | 2.4 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 0.7 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
| 0.1 | 0.7 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 0.1 | 2.2 | GO:0097433 | dense body(GO:0097433) |
| 0.1 | 3.3 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.1 | 0.3 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
| 0.1 | 0.5 | GO:0070931 | Golgi-associated vesicle lumen(GO:0070931) |
| 0.1 | 1.8 | GO:0000243 | commitment complex(GO:0000243) |
| 0.1 | 2.8 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
| 0.1 | 0.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
| 0.1 | 0.6 | GO:0031417 | NatC complex(GO:0031417) |
| 0.1 | 0.8 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 0.5 | GO:0060187 | cell pole(GO:0060187) |
| 0.1 | 0.5 | GO:0034684 | integrin alphav-beta5 complex(GO:0034684) |
| 0.1 | 0.5 | GO:0055087 | Ski complex(GO:0055087) |
| 0.1 | 3.9 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.1 | 2.6 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.1 | 0.6 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
| 0.1 | 3.8 | GO:1902711 | GABA-A receptor complex(GO:1902711) |
| 0.1 | 1.0 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
| 0.1 | 1.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 0.2 | GO:0005683 | U7 snRNP(GO:0005683) |
| 0.1 | 0.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 0.1 | 0.4 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.1 | 1.5 | GO:0033268 | node of Ranvier(GO:0033268) |
| 0.1 | 0.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.1 | 2.4 | GO:0031430 | M band(GO:0031430) |
| 0.1 | 5.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
| 0.1 | 2.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.1 | 2.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 0.8 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.1 | 1.7 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.1 | 0.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.1 | 0.3 | GO:1990812 | growth cone filopodium(GO:1990812) |
| 0.1 | 1.5 | GO:0043203 | axon hillock(GO:0043203) |
| 0.1 | 0.3 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.1 | 0.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
| 0.1 | 0.3 | GO:1990723 | cytoplasmic periphery of the nuclear pore complex(GO:1990723) |
| 0.1 | 0.4 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.1 | 6.6 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.1 | 1.0 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 1.9 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 8.3 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.7 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.1 | 1.3 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.1 | 0.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.1 | 0.4 | GO:1990876 | cytoplasmic side of nuclear pore(GO:1990876) |
| 0.1 | 0.9 | GO:0000836 | Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.1 | 0.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.1 | 0.7 | GO:0042599 | lamellar body(GO:0042599) |
| 0.1 | 0.4 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
| 0.1 | 2.8 | GO:0005640 | nuclear outer membrane(GO:0005640) |
| 0.1 | 0.9 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
| 0.1 | 0.2 | GO:0002139 | stereocilia coupling link(GO:0002139) |
| 0.1 | 1.3 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 1.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.1 | 0.7 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
| 0.1 | 0.4 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.1 | 1.5 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.1 | 1.0 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.1 | 0.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
| 0.1 | 1.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
| 0.1 | 8.2 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 1.5 | GO:0031045 | dense core granule(GO:0031045) |
| 0.1 | 2.5 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 0.5 | GO:0033565 | ESCRT-0 complex(GO:0033565) |
| 0.1 | 4.5 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
| 0.1 | 0.2 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.1 | 1.4 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
| 0.1 | 5.3 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 0.4 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.1 | 1.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
| 0.1 | 0.6 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 0.4 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
| 0.1 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
| 0.1 | 15.6 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.1 | 2.5 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.1 | 2.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 0.9 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.1 | 0.7 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 0.6 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 4.8 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 8.3 | GO:0042383 | sarcolemma(GO:0042383) |
| 0.1 | 1.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.6 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 7.1 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.1 | 1.5 | GO:0030658 | transport vesicle membrane(GO:0030658) |
| 0.1 | 2.9 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.1 | 8.0 | GO:0030016 | myofibril(GO:0030016) |
| 0.1 | 27.9 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 1.0 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
| 0.1 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 0.1 | 2.8 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 1.1 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.1 | 0.7 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.1 | 0.2 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
| 0.1 | 0.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.1 | 0.6 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
| 0.1 | 0.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 0.3 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.1 | 0.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 1.2 | GO:0032591 | dendritic spine membrane(GO:0032591) |
| 0.1 | 0.8 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 4.0 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 0.1 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.1 | 1.3 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 1.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.1 | 0.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.1 | 5.8 | GO:0043204 | perikaryon(GO:0043204) |
| 0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.1 | 0.2 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.1 | 11.2 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.1 | 0.7 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.0 | 15.5 | GO:0045211 | postsynaptic membrane(GO:0045211) |
| 0.0 | 0.1 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 0.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.0 | 0.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.0 | 0.4 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.0 | 1.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 1.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.0 | 0.2 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.0 | 0.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.0 | 1.8 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.0 | 1.9 | GO:0042734 | presynaptic membrane(GO:0042734) |
| 0.0 | 0.5 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
| 0.0 | 1.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
| 0.0 | 0.4 | GO:0042627 | chylomicron(GO:0042627) |
| 0.0 | 0.2 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
| 0.0 | 1.5 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.6 | GO:0030135 | coated vesicle(GO:0030135) |
| 0.0 | 0.3 | GO:0070826 | paraferritin complex(GO:0070826) |
| 0.0 | 0.8 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.0 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 2.3 | GO:0032420 | stereocilium(GO:0032420) |
| 0.0 | 0.1 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
| 0.0 | 6.1 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
| 0.0 | 0.8 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.0 | 0.7 | GO:0000974 | Prp19 complex(GO:0000974) |
| 0.0 | 0.1 | GO:0032998 | Fc receptor complex(GO:0032997) Fc-epsilon receptor I complex(GO:0032998) |
| 0.0 | 0.7 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
| 0.0 | 0.8 | GO:0034518 | RNA cap binding complex(GO:0034518) |
| 0.0 | 0.2 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
| 0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.0 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
| 0.0 | 0.2 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.0 | 0.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
| 0.0 | 0.5 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.0 | 1.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.0 | 0.3 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
| 0.0 | 0.6 | GO:0000813 | ESCRT I complex(GO:0000813) |
| 0.0 | 2.1 | GO:0005902 | microvillus(GO:0005902) |
| 0.0 | 5.8 | GO:0016605 | PML body(GO:0016605) |
| 0.0 | 1.0 | GO:0097060 | synaptic membrane(GO:0097060) |
| 0.0 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
| 0.0 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
| 0.0 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.0 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.0 | 2.7 | GO:0005637 | nuclear inner membrane(GO:0005637) |
| 0.0 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
| 0.0 | 1.1 | GO:0001726 | ruffle(GO:0001726) |
| 0.0 | 0.2 | GO:0044295 | axonal growth cone(GO:0044295) |
| 0.0 | 0.8 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.0 | 0.5 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
| 0.0 | 0.2 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.0 | 0.3 | GO:0036019 | endolysosome(GO:0036019) |
| 0.0 | 0.3 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.0 | 5.6 | GO:0005875 | microtubule associated complex(GO:0005875) |
| 0.0 | 0.2 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.0 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.0 | 0.5 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.0 | 0.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.0 | 0.2 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.0 | 0.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.0 | 1.9 | GO:0005776 | autophagosome(GO:0005776) |
| 0.0 | 8.6 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.0 | 1.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.0 | 0.2 | GO:0044423 | virion(GO:0019012) virion part(GO:0044423) |
| 0.0 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.0 | 0.6 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.0 | 1.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.0 | 0.2 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.0 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
| 0.0 | 0.2 | GO:0032044 | DSIF complex(GO:0032044) |
| 0.0 | 0.5 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.0 | 2.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
| 0.0 | 1.1 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 0.5 | GO:0005929 | cilium(GO:0005929) |
| 0.0 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
| 0.0 | 0.1 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.0 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.0 | 0.6 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 0.7 | GO:0098827 | endoplasmic reticulum tubular network(GO:0071782) endoplasmic reticulum subcompartment(GO:0098827) |
| 0.0 | 0.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
| 0.0 | 0.3 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.0 | 0.3 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) |
| 0.0 | 0.8 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.0 | 27.6 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.0 | 0.8 | GO:0043195 | terminal bouton(GO:0043195) |
| 0.0 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.0 | 0.5 | GO:0097014 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.0 | 0.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
| 0.0 | 0.2 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.0 | 1.9 | GO:0030427 | site of polarized growth(GO:0030427) |
| 0.0 | 1.5 | GO:0060170 | ciliary membrane(GO:0060170) |
| 0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.0 | 5.3 | GO:0043025 | neuronal cell body(GO:0043025) |
| 0.0 | 3.1 | GO:0031901 | early endosome membrane(GO:0031901) |
| 0.0 | 0.0 | GO:0097598 | sperm cytoplasmic droplet(GO:0097598) |
| 0.0 | 0.1 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.0 | 4.3 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.1 | GO:0072686 | mitotic spindle(GO:0072686) |
| 0.0 | 1.2 | GO:0016363 | nuclear matrix(GO:0016363) |
| 0.0 | 0.1 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.0 | 1.0 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.0 | 0.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
| 0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 0.1 | GO:0071942 | XPC complex(GO:0071942) |
| 0.0 | 7.0 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
| 0.0 | 0.1 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.0 | 17.6 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
| 0.0 | 0.8 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.0 | 0.1 | GO:0070985 | TFIIK complex(GO:0070985) |
| 0.0 | 1.6 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 0.9 | GO:0032432 | actin filament bundle(GO:0032432) |
| 0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.0 | 0.1 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.0 | 0.3 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.0 | 0.0 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
| 0.0 | 0.1 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.0 | 0.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.0 | 0.2 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.1 | GO:0005605 | basal lamina(GO:0005605) |
| 0.0 | 0.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.0 | 2.1 | GO:0001650 | fibrillar center(GO:0001650) |
| 0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.0 | 0.1 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
| 0.0 | 1.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
| 0.0 | 0.2 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.7 | 11.0 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
| 1.5 | 4.6 | GO:0015068 | amidinotransferase activity(GO:0015067) glycine amidinotransferase activity(GO:0015068) |
| 1.5 | 6.0 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
| 1.1 | 5.4 | GO:0003875 | ADP-ribosylarginine hydrolase activity(GO:0003875) |
| 0.8 | 2.5 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
| 0.8 | 4.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
| 0.8 | 2.3 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 0.7 | 2.9 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
| 0.7 | 2.2 | GO:0061663 | NEDD8 ligase activity(GO:0061663) |
| 0.7 | 30.3 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.7 | 2.0 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
| 0.7 | 2.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
| 0.7 | 22.6 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
| 0.7 | 2.6 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
| 0.6 | 1.9 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.6 | 3.0 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.6 | 2.4 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
| 0.6 | 4.1 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
| 0.6 | 12.8 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.5 | 4.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.5 | 11.2 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
| 0.5 | 2.6 | GO:0102008 | cytosolic dipeptidase activity(GO:0102008) |
| 0.5 | 2.7 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.4 | 2.2 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
| 0.4 | 3.1 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.4 | 1.7 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
| 0.4 | 2.1 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
| 0.4 | 1.2 | GO:0047536 | 2-aminoadipate transaminase activity(GO:0047536) |
| 0.4 | 4.4 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.4 | 1.2 | GO:0035248 | alpha-1,4-N-acetylgalactosaminyltransferase activity(GO:0035248) |
| 0.4 | 3.6 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.4 | 1.5 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.4 | 6.9 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.4 | 0.8 | GO:0016887 | ATPase activity(GO:0016887) |
| 0.4 | 1.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.4 | 1.9 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.4 | 1.5 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
| 0.4 | 1.8 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.4 | 2.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
| 0.4 | 1.1 | GO:0080130 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
| 0.4 | 1.4 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.3 | 2.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.3 | 1.0 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) polyamine binding(GO:0019808) |
| 0.3 | 2.4 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.3 | 2.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
| 0.3 | 4.8 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.3 | 1.0 | GO:0070283 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
| 0.3 | 2.8 | GO:0050682 | AF-2 domain binding(GO:0050682) |
| 0.3 | 1.0 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
| 0.3 | 2.7 | GO:0031782 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 0.3 | 2.0 | GO:0008940 | nitrate reductase activity(GO:0008940) |
| 0.3 | 1.3 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.3 | 5.0 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.3 | 1.0 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
| 0.3 | 3.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.3 | 1.0 | GO:1904854 | proteasome core complex binding(GO:1904854) |
| 0.3 | 4.8 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
| 0.3 | 2.2 | GO:0016403 | dimethylargininase activity(GO:0016403) |
| 0.3 | 1.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
| 0.3 | 1.2 | GO:0070704 | C-5 sterol desaturase activity(GO:0000248) sterol desaturase activity(GO:0070704) |
| 0.3 | 1.2 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
| 0.3 | 1.2 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
| 0.3 | 2.4 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.3 | 2.1 | GO:0046556 | alpha-L-arabinofuranosidase activity(GO:0046556) |
| 0.3 | 0.9 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
| 0.3 | 1.2 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
| 0.3 | 1.2 | GO:0015207 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
| 0.3 | 1.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.3 | 1.2 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
| 0.3 | 1.1 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
| 0.3 | 2.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.3 | 1.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.3 | 0.8 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.3 | 0.8 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
| 0.3 | 1.6 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
| 0.3 | 0.8 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
| 0.3 | 2.1 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
| 0.3 | 2.6 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.3 | 0.8 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
| 0.3 | 1.3 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
| 0.3 | 2.6 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
| 0.3 | 1.0 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.3 | 1.8 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
| 0.3 | 13.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.3 | 1.0 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
| 0.3 | 0.8 | GO:0015633 | zinc transporting ATPase activity(GO:0015633) |
| 0.3 | 1.0 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
| 0.3 | 0.5 | GO:0005137 | interleukin-5 receptor binding(GO:0005137) |
| 0.2 | 1.2 | GO:0004556 | alpha-amylase activity(GO:0004556) |
| 0.2 | 2.0 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
| 0.2 | 1.7 | GO:0032557 | UTP:glucose-1-phosphate uridylyltransferase activity(GO:0003983) pyrimidine ribonucleotide binding(GO:0032557) UTP-monosaccharide-1-phosphate uridylyltransferase activity(GO:0051748) |
| 0.2 | 1.0 | GO:1990175 | EH domain binding(GO:1990175) |
| 0.2 | 0.7 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 0.2 | 0.5 | GO:0043531 | ADP binding(GO:0043531) |
| 0.2 | 6.7 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
| 0.2 | 0.7 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.2 | 15.0 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.2 | 1.4 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
| 0.2 | 3.0 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.2 | 0.9 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
| 0.2 | 3.2 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.2 | 0.7 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
| 0.2 | 0.7 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.2 | 0.9 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
| 0.2 | 1.1 | GO:0033265 | acetylcholinesterase activity(GO:0003990) choline binding(GO:0033265) |
| 0.2 | 1.3 | GO:0004925 | prolactin receptor activity(GO:0004925) |
| 0.2 | 1.5 | GO:0035473 | lipase binding(GO:0035473) |
| 0.2 | 0.9 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.2 | 3.2 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.2 | 0.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.2 | 1.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
| 0.2 | 1.1 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
| 0.2 | 2.5 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
| 0.2 | 1.1 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.2 | 0.6 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
| 0.2 | 1.5 | GO:0052739 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) |
| 0.2 | 1.4 | GO:0099580 | ion antiporter activity involved in regulation of postsynaptic membrane potential(GO:0099580) |
| 0.2 | 0.6 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
| 0.2 | 0.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.2 | 0.6 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
| 0.2 | 2.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.2 | 1.5 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
| 0.2 | 0.7 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.2 | 0.9 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.2 | 1.6 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.2 | 0.2 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.2 | 0.5 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.2 | 1.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.2 | 2.1 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.2 | 2.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.2 | 0.5 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
| 0.2 | 0.9 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
| 0.2 | 0.5 | GO:0033961 | cis-stilbene-oxide hydrolase activity(GO:0033961) |
| 0.2 | 1.0 | GO:0044594 | 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
| 0.2 | 3.7 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
| 0.2 | 1.0 | GO:0004797 | deoxycytidine kinase activity(GO:0004137) thymidine kinase activity(GO:0004797) |
| 0.2 | 1.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.2 | 0.5 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
| 0.2 | 3.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.2 | 1.4 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.2 | 1.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.2 | 1.2 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 0.2 | 0.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
| 0.2 | 0.7 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
| 0.2 | 1.0 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.2 | 2.8 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.2 | 2.8 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.2 | 1.0 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
| 0.2 | 0.8 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
| 0.2 | 2.7 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
| 0.2 | 2.2 | GO:1903136 | cuprous ion binding(GO:1903136) |
| 0.2 | 1.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.2 | 0.3 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
| 0.2 | 0.5 | GO:0008441 | 3'(2'),5'-bisphosphate nucleotidase activity(GO:0008441) |
| 0.2 | 0.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 0.2 | 1.1 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
| 0.2 | 3.6 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.2 | 4.2 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
| 0.2 | 0.6 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.1 | 2.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
| 0.1 | 0.6 | GO:0019862 | IgA binding(GO:0019862) |
| 0.1 | 1.0 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.1 | 1.9 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.1 | 0.3 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.1 | 0.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.1 | 1.7 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.1 | 1.3 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 2.9 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
| 0.1 | 0.4 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.1 | 0.4 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
| 0.1 | 1.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
| 0.1 | 0.6 | GO:0015616 | DNA translocase activity(GO:0015616) |
| 0.1 | 4.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.1 | 0.4 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.1 | 0.7 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.1 | 0.6 | GO:0016608 | growth hormone-releasing hormone activity(GO:0016608) |
| 0.1 | 1.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
| 0.1 | 2.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
| 0.1 | 1.1 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.1 | 0.5 | GO:0061714 | folic acid receptor activity(GO:0061714) |
| 0.1 | 0.4 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
| 0.1 | 0.4 | GO:0005135 | interleukin-3 receptor binding(GO:0005135) |
| 0.1 | 0.4 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
| 0.1 | 1.2 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.1 | 0.8 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
| 0.1 | 1.9 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.1 | 0.3 | GO:0051870 | methotrexate binding(GO:0051870) |
| 0.1 | 0.6 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.1 | 3.0 | GO:0015643 | toxic substance binding(GO:0015643) |
| 0.1 | 1.3 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
| 0.1 | 0.3 | GO:1990446 | snRNP binding(GO:0070990) U1 snRNP binding(GO:1990446) |
| 0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 0.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
| 0.1 | 0.3 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
| 0.1 | 1.6 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 3.6 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.1 | 2.1 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.1 | 7.9 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.1 | 0.4 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
| 0.1 | 0.4 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
| 0.1 | 1.6 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.1 | 0.7 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
| 0.1 | 3.5 | GO:0031005 | filamin binding(GO:0031005) |
| 0.1 | 0.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 0.1 | 2.4 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.1 | 0.5 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
| 0.1 | 0.4 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
| 0.1 | 1.0 | GO:0015184 | L-cystine transmembrane transporter activity(GO:0015184) |
| 0.1 | 1.0 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
| 0.1 | 1.7 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.5 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.1 | 0.8 | GO:0034046 | poly(G) binding(GO:0034046) |
| 0.1 | 2.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.1 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
| 0.1 | 0.2 | GO:0052856 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
| 0.1 | 0.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
| 0.1 | 0.7 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.1 | 1.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
| 0.1 | 1.4 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.1 | 1.1 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.1 | 0.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
| 0.1 | 0.7 | GO:0042015 | interleukin-20 binding(GO:0042015) |
| 0.1 | 0.9 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
| 0.1 | 2.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
| 0.1 | 1.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.1 | 0.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 0.4 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.1 | 0.4 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
| 0.1 | 5.5 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.1 | 0.5 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
| 0.1 | 1.7 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.1 | 2.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
| 0.1 | 1.3 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.1 | 0.2 | GO:0043559 | insulin binding(GO:0043559) |
| 0.1 | 3.3 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 0.8 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.1 | 2.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.1 | 1.2 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.1 | 0.5 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
| 0.1 | 0.8 | GO:0034711 | inhibin binding(GO:0034711) |
| 0.1 | 0.3 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.1 | 9.0 | GO:0050840 | extracellular matrix binding(GO:0050840) |
| 0.1 | 1.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.1 | 0.5 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
| 0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
| 0.1 | 0.3 | GO:0070538 | oleic acid binding(GO:0070538) |
| 0.1 | 0.5 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
| 0.1 | 0.5 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.1 | 1.5 | GO:0031432 | titin binding(GO:0031432) |
| 0.1 | 4.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 2.9 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 1.1 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
| 0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.1 | 1.8 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
| 0.1 | 0.6 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
| 0.1 | 0.9 | GO:0031433 | telethonin binding(GO:0031433) |
| 0.1 | 0.8 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
| 0.1 | 0.4 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 0.1 | 0.8 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.1 | 0.3 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.1 | 2.0 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 2.7 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
| 0.1 | 0.6 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 0.7 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.1 | 0.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.1 | 0.6 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.1 | 2.9 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
| 0.1 | 3.9 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.1 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
| 0.1 | 0.7 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
| 0.1 | 0.4 | GO:1904408 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
| 0.1 | 2.8 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.1 | 1.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.1 | 1.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.1 | 0.9 | GO:0090079 | translation activator activity(GO:0008494) translation regulator activity, nucleic acid binding(GO:0090079) |
| 0.1 | 0.5 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.1 | 3.9 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.1 | 2.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
| 0.1 | 0.3 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.1 | 0.3 | GO:1902271 | D3 vitamins binding(GO:1902271) |
| 0.1 | 0.5 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.1 | 0.5 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
| 0.1 | 0.5 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
| 0.1 | 0.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.1 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
| 0.1 | 3.0 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
| 0.1 | 0.2 | GO:0004040 | amidase activity(GO:0004040) |
| 0.1 | 1.2 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.5 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
| 0.1 | 1.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
| 0.1 | 3.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 3.0 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
| 0.1 | 0.3 | GO:0035514 | DNA demethylase activity(GO:0035514) |
| 0.1 | 2.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 1.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
| 0.1 | 0.9 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.1 | 4.3 | GO:0005254 | chloride channel activity(GO:0005254) |
| 0.1 | 0.4 | GO:0031403 | lithium ion binding(GO:0031403) |
| 0.1 | 0.6 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.1 | 12.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
| 0.1 | 0.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.1 | 1.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 0.1 | 1.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.1 | 2.6 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 0.6 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.4 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.1 | 0.8 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) G-quadruplex DNA binding(GO:0051880) |
| 0.1 | 0.5 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.1 | 2.9 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
| 0.1 | 0.3 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
| 0.1 | 1.3 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
| 0.1 | 3.6 | GO:0008168 | methyltransferase activity(GO:0008168) |
| 0.1 | 2.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 1.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
| 0.1 | 1.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.5 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
| 0.1 | 0.4 | GO:0052829 | inositol-1,4-bisphosphate 1-phosphatase activity(GO:0004441) inositol-1,3,4-trisphosphate 1-phosphatase activity(GO:0052829) |
| 0.1 | 1.6 | GO:0008430 | selenium binding(GO:0008430) |
| 0.1 | 1.4 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.1 | 0.9 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
| 0.1 | 1.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
| 0.1 | 5.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
| 0.1 | 1.5 | GO:0043295 | glutathione binding(GO:0043295) |
| 0.1 | 1.5 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.1 | 1.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 0.9 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.1 | 0.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 0.1 | 0.2 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.1 | 2.6 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.1 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.1 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.1 | 0.6 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
| 0.1 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.1 | 1.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.1 | 3.2 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.1 | 0.8 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 1.8 | GO:0043495 | protein anchor(GO:0043495) |
| 0.1 | 2.4 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 1.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 0.1 | GO:0017076 | purine nucleotide binding(GO:0017076) |
| 0.1 | 0.7 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
| 0.1 | 1.3 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.1 | 0.5 | GO:0008312 | 7S RNA binding(GO:0008312) |
| 0.1 | 0.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.1 | 1.1 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
| 0.1 | 1.3 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 2.5 | GO:0005504 | fatty acid binding(GO:0005504) |
| 0.1 | 0.7 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.1 | 1.1 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 0.4 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.1 | 1.2 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 0.6 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.1 | 0.3 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
| 0.1 | 0.5 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
| 0.1 | 2.3 | GO:0008175 | tRNA methyltransferase activity(GO:0008175) |
| 0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 0.3 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
| 0.1 | 1.3 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
| 0.1 | 1.9 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.1 | 3.0 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.2 | GO:0050664 | superoxide-generating NADPH oxidase activity(GO:0016175) oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
| 0.1 | 0.4 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.1 | 0.9 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 0.4 | GO:0001875 | lipopolysaccharide receptor activity(GO:0001875) |
| 0.1 | 0.5 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
| 0.1 | 1.6 | GO:0042805 | actinin binding(GO:0042805) |
| 0.1 | 0.6 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.1 | 0.2 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
| 0.1 | 0.3 | GO:0070905 | serine binding(GO:0070905) |
| 0.1 | 0.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.1 | 0.5 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
| 0.1 | 0.2 | GO:0004817 | cysteine-tRNA ligase activity(GO:0004817) |
| 0.1 | 0.5 | GO:0033857 | diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.1 | 1.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.1 | 0.2 | GO:0005497 | androgen binding(GO:0005497) |
| 0.1 | 0.4 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
| 0.1 | 0.2 | GO:0032184 | SUMO polymer binding(GO:0032184) |
| 0.1 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
| 0.1 | 0.2 | GO:0052854 | (S)-2-hydroxy-acid oxidase activity(GO:0003973) oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) very-long-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052852) long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity(GO:0052853) medium-chain-(S)-2-hydroxy-acid oxidase activity(GO:0052854) |
| 0.1 | 0.7 | GO:0030553 | cGMP binding(GO:0030553) |
| 0.1 | 0.7 | GO:0015172 | L-glutamate transmembrane transporter activity(GO:0005313) acidic amino acid transmembrane transporter activity(GO:0015172) |
| 0.1 | 2.1 | GO:0030552 | cAMP binding(GO:0030552) |
| 0.1 | 1.6 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
| 0.1 | 0.4 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.1 | 1.3 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
| 0.1 | 1.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.1 | 0.2 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.1 | 0.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.1 | 0.3 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
| 0.1 | 2.0 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 0.2 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 0.1 | 0.4 | GO:0004771 | sterol esterase activity(GO:0004771) |
| 0.1 | 0.3 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.1 | 1.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
| 0.1 | 2.4 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.1 | 3.2 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
| 0.1 | 0.5 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.1 | 0.2 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
| 0.1 | 18.4 | GO:0008017 | microtubule binding(GO:0008017) |
| 0.1 | 0.4 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
| 0.1 | 0.3 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.1 | 1.1 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 2.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
| 0.1 | 2.5 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.0 | 0.1 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
| 0.0 | 1.7 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
| 0.0 | 2.6 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.0 | 0.5 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.0 | 0.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
| 0.0 | 0.7 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 0.6 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.0 | 0.2 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
| 0.0 | 0.2 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
| 0.0 | 0.4 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.0 | 0.5 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
| 0.0 | 0.7 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
| 0.0 | 0.1 | GO:0001016 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) RNA polymerase III regulatory region DNA binding(GO:0001016) RNA polymerase III type 1 promoter DNA binding(GO:0001030) RNA polymerase III type 2 promoter DNA binding(GO:0001031) 5S rDNA binding(GO:0080084) |
| 0.0 | 0.1 | GO:0016503 | pheromone receptor activity(GO:0016503) |
| 0.0 | 0.2 | GO:0098625 | methylselenol reductase activity(GO:0098625) methylseleninic acid reductase activity(GO:0098626) |
| 0.0 | 1.8 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.0 | 1.5 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.0 | 0.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.0 | 0.3 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.0 | 0.4 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.0 | 0.5 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
| 0.0 | 0.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
| 0.0 | 0.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.0 | 0.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.0 | 0.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.0 | 0.3 | GO:0004857 | enzyme inhibitor activity(GO:0004857) |
| 0.0 | 0.2 | GO:0016005 | phospholipase A2 activator activity(GO:0016005) |
| 0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.0 | 1.3 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.0 | 1.8 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.8 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.0 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.0 | 0.4 | GO:0016015 | morphogen activity(GO:0016015) |
| 0.0 | 1.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 0.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.0 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
| 0.0 | 0.3 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
| 0.0 | 0.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
| 0.0 | 0.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.0 | 0.2 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
| 0.0 | 1.0 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 0.2 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.0 | 2.3 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.0 | 1.0 | GO:0071949 | FAD binding(GO:0071949) |
| 0.0 | 1.0 | GO:0004033 | aldo-keto reductase (NADP) activity(GO:0004033) |
| 0.0 | 0.2 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.0 | 1.1 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) |
| 0.0 | 0.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 0.0 | 0.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.0 | 0.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.0 | 0.3 | GO:0015272 | ATP-activated inward rectifier potassium channel activity(GO:0015272) |
| 0.0 | 0.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.0 | 1.5 | GO:0035254 | glutamate receptor binding(GO:0035254) |
| 0.0 | 0.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.0 | 0.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.0 | 0.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.0 | 2.4 | GO:1901476 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
| 0.0 | 3.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
| 0.0 | 1.0 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.0 | 2.0 | GO:0048365 | Rac GTPase binding(GO:0048365) |
| 0.0 | 0.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.0 | 0.1 | GO:0008761 | UDP-N-acetylglucosamine 2-epimerase activity(GO:0008761) N-acylmannosamine kinase activity(GO:0009384) |
| 0.0 | 1.8 | GO:0005158 | insulin receptor binding(GO:0005158) |
| 0.0 | 0.4 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.0 | 0.1 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
| 0.0 | 0.7 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
| 0.0 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.0 | 0.6 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.0 | 1.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
| 0.0 | 0.6 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
| 0.0 | 4.1 | GO:0044325 | ion channel binding(GO:0044325) |
| 0.0 | 0.2 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.0 | 0.6 | GO:0070513 | death domain binding(GO:0070513) |
| 0.0 | 1.5 | GO:0015085 | calcium ion transmembrane transporter activity(GO:0015085) |
| 0.0 | 5.0 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.0 | 1.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 2.3 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
| 0.0 | 1.1 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.2 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
| 0.0 | 0.5 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
| 0.0 | 0.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 0.3 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
| 0.0 | 0.5 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 2.0 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
| 0.0 | 5.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.0 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
| 0.0 | 1.3 | GO:0043621 | protein self-association(GO:0043621) |
| 0.0 | 0.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.0 | 0.6 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.0 | 0.8 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 0.2 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
| 0.0 | 0.4 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.0 | 1.2 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.0 | 0.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.0 | 0.5 | GO:0030618 | transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 0.2 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.0 | 0.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
| 0.0 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.0 | 0.3 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
| 0.0 | 0.8 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.0 | 0.3 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.7 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
| 0.0 | 0.1 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.0 | 2.7 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.3 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
| 0.0 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
| 0.0 | 20.3 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 0.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.0 | 0.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
| 0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.0 | 0.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.0 | 0.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
| 0.0 | 0.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.0 | 0.5 | GO:0016854 | racemase and epimerase activity(GO:0016854) |
| 0.0 | 0.2 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.0 | 13.9 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.4 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.0 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
| 0.0 | 0.2 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.0 | 3.2 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.2 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.0 | 3.0 | GO:0005516 | calmodulin binding(GO:0005516) |
| 0.0 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.0 | 0.2 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
| 0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.2 | GO:0030983 | mismatched DNA binding(GO:0030983) |
| 0.0 | 0.6 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.0 | 1.7 | GO:0008013 | beta-catenin binding(GO:0008013) |
| 0.0 | 0.1 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.0 | 0.6 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
| 0.0 | 0.5 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
| 0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
| 0.0 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.0 | 0.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 0.9 | GO:0008028 | monocarboxylic acid transmembrane transporter activity(GO:0008028) |
| 0.0 | 4.0 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.0 | 0.2 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
| 0.0 | 0.1 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
| 0.0 | 0.8 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.0 | 0.2 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
| 0.0 | 0.4 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
| 0.0 | 0.1 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.0 | 0.1 | GO:0004849 | uridine kinase activity(GO:0004849) |
| 0.0 | 0.9 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.0 | 0.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.0 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
| 0.0 | 0.3 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.0 | 0.4 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.2 | GO:0000150 | recombinase activity(GO:0000150) |
| 0.0 | 0.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.0 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.1 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
| 0.0 | 0.1 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
| 0.0 | 0.1 | GO:0042043 | neurexin family protein binding(GO:0042043) |
| 0.0 | 0.4 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.0 | 0.1 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
| 0.0 | 0.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.2 | 12.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.1 | 1.0 | PID BARD1 PATHWAY | BARD1 signaling events |
| 0.1 | 1.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
| 0.1 | 2.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.1 | 1.0 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 4.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
| 0.1 | 9.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.1 | 0.6 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
| 0.1 | 2.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.1 | 2.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 3.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
| 0.1 | 1.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.1 | 3.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
| 0.1 | 2.0 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.1 | 2.6 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.1 | 2.2 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.1 | 5.0 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.1 | 3.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.1 | 0.5 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 4.8 | PID AURORA A PATHWAY | Aurora A signaling |
| 0.1 | 0.5 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
| 0.1 | 0.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
| 0.1 | 0.1 | PID TRAIL PATHWAY | TRAIL signaling pathway |
| 0.1 | 4.4 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
| 0.1 | 0.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 1.4 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.0 | 2.5 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
| 0.0 | 1.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
| 0.0 | 0.8 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
| 0.0 | 0.4 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.4 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
| 0.0 | 0.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.0 | 0.3 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.0 | 4.3 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
| 0.0 | 0.4 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.0 | 2.5 | PID INSULIN PATHWAY | Insulin Pathway |
| 0.0 | 0.4 | PID ERBB4 PATHWAY | ErbB4 signaling events |
| 0.0 | 1.5 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
| 0.0 | 0.8 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
| 0.0 | 1.9 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 2.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.4 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
| 0.0 | 2.4 | PID MTOR 4PATHWAY | mTOR signaling pathway |
| 0.0 | 1.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.0 | 0.7 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
| 0.0 | 0.7 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.0 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.0 | 0.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
| 0.0 | 1.0 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.0 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.7 | PID FOXO PATHWAY | FoxO family signaling |
| 0.0 | 1.0 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.0 | 0.2 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.0 | 0.7 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
| 0.0 | 2.2 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
| 0.0 | 0.7 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.0 | 0.3 | ST G ALPHA S PATHWAY | G alpha s Pathway |
| 0.0 | 2.7 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.5 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
| 0.0 | 1.9 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.0 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
| 0.0 | 6.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 0.9 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
| 0.0 | 1.2 | PID BMP PATHWAY | BMP receptor signaling |
| 0.0 | 0.7 | PID RAS PATHWAY | Regulation of Ras family activation |
| 0.0 | 0.9 | PID LKB1 PATHWAY | LKB1 signaling events |
| 0.0 | 0.3 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.0 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.0 | 1.4 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
| 0.0 | 1.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.0 | 0.2 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 0.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 0.1 | ST GAQ PATHWAY | G alpha q Pathway |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 13.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.3 | 9.5 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.2 | 3.1 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
| 0.2 | 3.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.2 | 11.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.2 | 9.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 3.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.2 | 2.7 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 14.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
| 0.1 | 5.3 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.1 | 4.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 3.9 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
| 0.1 | 2.3 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
| 0.1 | 1.4 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.1 | 4.6 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
| 0.1 | 5.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.1 | 3.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.1 | 2.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.1 | 3.0 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.1 | 2.0 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 2.5 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
| 0.1 | 1.8 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.1 | 5.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
| 0.1 | 2.8 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.1 | 5.0 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.1 | 0.5 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.1 | 2.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 4.2 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.1 | 4.4 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
| 0.1 | 1.7 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.1 | 6.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 3.9 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 7.5 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
| 0.1 | 6.2 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 0.6 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.1 | 2.9 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
| 0.1 | 3.6 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
| 0.1 | 22.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
| 0.1 | 4.1 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
| 0.1 | 2.9 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 2.9 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 3.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
| 0.1 | 1.8 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
| 0.1 | 2.8 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.1 | 0.4 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.1 | 0.2 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
| 0.1 | 2.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.1 | 3.1 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.1 | 1.4 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.1 | 1.8 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 1.9 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 0.2 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
| 0.1 | 1.6 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 0.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.1 | 1.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.1 | 1.3 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.1 | 0.8 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
| 0.1 | 1.6 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
| 0.1 | 1.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
| 0.1 | 1.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.1 | 2.2 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 0.7 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
| 0.1 | 2.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
| 0.1 | 1.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.0 | 3.8 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 2.4 | REACTOME FORMATION OF TRANSCRIPTION COUPLED NER TC NER REPAIR COMPLEX | Genes involved in Formation of transcription-coupled NER (TC-NER) repair complex |
| 0.0 | 1.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
| 0.0 | 4.5 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.0 | 2.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 2.9 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
| 0.0 | 2.0 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
| 0.0 | 12.7 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.0 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
| 0.0 | 2.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
| 0.0 | 0.4 | REACTOME ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK EPSILON | Genes involved in Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon |
| 0.0 | 0.5 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
| 0.0 | 0.9 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.0 | 1.0 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.0 | 1.2 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
| 0.0 | 1.0 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.0 | 1.0 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
| 0.0 | 1.0 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.0 | 0.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.0 | 1.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.0 | 0.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.0 | 1.0 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 1.6 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.0 | 0.9 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
| 0.0 | 0.6 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.0 | 0.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.0 | 0.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
| 0.0 | 1.0 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
| 0.0 | 0.8 | REACTOME METABOLISM OF MRNA | Genes involved in Metabolism of mRNA |
| 0.0 | 0.2 | REACTOME SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.0 | 2.6 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
| 0.0 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
| 0.0 | 0.9 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 0.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.0 | 1.6 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
| 0.0 | 1.2 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.0 | 0.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
| 0.0 | 0.1 | REACTOME SIGNALING BY ERBB4 | Genes involved in Signaling by ERBB4 |
| 0.0 | 2.5 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.7 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.0 | 0.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.0 | 0.9 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
| 0.0 | 0.6 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.0 | 0.6 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.0 | 0.5 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
| 0.0 | 1.4 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.0 | 4.2 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.0 | 1.0 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
| 0.0 | 0.2 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
| 0.0 | 0.7 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
| 0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.0 | 0.7 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
| 0.0 | 7.6 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.0 | 4.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.0 | 0.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
| 0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.0 | 1.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.0 | 1.0 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.0 | 0.2 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
| 0.0 | 0.2 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.0 | 0.6 | REACTOME RNA POL I RNA POL III AND MITOCHONDRIAL TRANSCRIPTION | Genes involved in RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription |
| 0.0 | 0.4 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
| 0.0 | 0.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
| 0.0 | 0.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
| 0.0 | 0.4 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
| 0.0 | 1.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
| 0.0 | 0.8 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
| 0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.0 | 1.2 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
| 0.0 | 0.3 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
| 0.0 | 0.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.0 | 0.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
| 0.0 | 0.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.0 | 0.1 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |